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   Cardiovascular disease (CVD) accounts for 37.1 percent of all deaths in the 
United States. Physical activity is inversely related to both CV event risk and to 
many of the individual CVD risk factors.  The inverse relationship between 
physical activity and CVD risk is well established. However, much dispute 
remains about the optimal physical activity intensity and duration related to health 
benefits and to lower CVD risk. The ability to objectively measure intensity and 
duration may clarify the inverse relationship between physical activity and CVD. 
The purpose of this collection of studies was to explore the association of 
physical activity with CVD and attempt to identify some specifics of this complex 
relationship. Results: In healthy sedentary individuals aged 31 to 66, 2 different 
activity accumulation programs were effective in increasing physical activity and 
resulted in improved fitness and blood glucose. However, the improvement in 
activity was not of sufficient intensity to provide changes in multiple heart disease 
risk factors or inflammation. In a cross-section sample of males and females 
aged 18 to 65, both active and sedentary, the relationship between physical 
activity and CVD risk varied by age group. The inverse relationship between 
physical activity and CVD risk was confirmed. However, reaching higher intensity 
levels for 1 minute periods at least 5 minutes a day appears to be better related 
to lower risk of CVD than longer durations of moderate or vigorous activity per 
day, particularly in younger individuals.  In a sample of stroke survivors aged 50 
to 72, 3 out of 6 of the modifiable risk factors for CVD were present. In these 
stroke survivors, physical activity intensity and duration were well below current 
recommendations and insufficient for CVD risk reduction. Conclusions: 
Accumulating activity can be effective in meeting physical activity 
recommendations however both duration and intensity requirements must be 
achieved. Combinations of higher intensities for shorter durations may also be 
effective in CVD risk reduction.  
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GLOSSARY 
 
 
 
6 minute walk. A submaximal functional exercise test that correlates with 
maximal oxygen uptake   
 
accelerometer. A motion sensor device used to objectively measure physical 
activity by continuously recording multidirectional movement   
 
acidosis. An increased acidity or increased hydrogen ion (H+) concentration in 
the bloodstream due to increased production of H+ by the body  
 
Actical. Brand name of accelerometer made by Mini Mitter and Respironics®  
 
Active Living Everyday® (ALED). An educational program designed to promote  
increasing physical activity through changes in lifestyle 
 
activity monitor. A term used to generically describe devices that measure  
physical activity like an accelerometer  
 
acute phase response. A body defense that occurs during acute illnesses 
involving increased production of blood proteins termed acute phase 
proteins like C-reactive protein that are produced by cells in the liver that 
promote inflammation 
 
acute phase protein. A cytokine protein whose plasma concentration increases 
by 25% or more during an acute inflammatory response 
 
aerobic fitness. The ability of the circulatory and respiratory systems to supply  
oxygen to skeletal muscles during sustained physical activity. The 
quantification of the ability to sustain work for prolonged periods 
 
anaerobic metabolism. Energy utilization (catabolism) that is not dependent on 
oxygen  
 
angiography. The radiographic visualization of the blood vessels after injection 
of a radiopaque substance 
 
assay. Analysis of a substance to determine the presence, absence, or quantity 
of one or more components 
 
atherosclerosis. A progressive disease process characterized by an 
accumulation of abnormal fatty deposits (plaque) in the inner layer of the 
arteries (endothelium) 
 viii
 
 
 
basal metabolic rate. The minimal level of energy required to sustain vital 
functions in the waking state  
 
body mass index (BMI). A commonly used measure of body fatness calculated 
by dividing the weight (kilograms) of an individual by their height (meters) 
squared  
 
Borg rating of perceived exertion (RPE). A measurement scale used to obtain 
quantitative identification of the feeling of fatigue that is highly correlated 
with heart rate 
 
calorimetry. A non-invasive measurement of energy expenditure using oxygen 
consumption 
 
cardioprotective. Anything that reduces risk or problems related to the heart 
 
cardiorespiratory fitness. The ability of the circulatory and respiratory systems 
to supply oxygen to skeletal muscles during sustained physical activity  
 
cardiovascular disease (CVD). A class of diseases that involve the heart or 
blood vessels usually used to refer to those related to atherosclerosis 
 
cardiovascular events. An incident related to or caused by cardiovascular 
disease (atherosclerosis) causing temporary or permanent blockage of an 
artery and resulting in damage to an organ (heart, brain) supplied by the 
artery  
 
cell adhesion molecules. Molecules that regulate the binding of a cell to 
another cell or to a surface or matrix 
 
cerebrovascular accident (CVA). Also known as stroke. A loss of a portion of 
brain function due to an interruption in the blood supply to part of the brain 
 
coronary heart disease (CHD). The result of the accumulation of atherosclerotic 
plaques within the walls of the arteries that supply the heart  
 
C-reactive protein (CRP). An acute phase protein (cytokine) produced by the 
liver found in the plasma and used as a marker of systemic inflammation 
 
cytokines. Small secreted proteins which mediate and regulate immunity and 
inflammation 
 
cytotoxic. Any agent or process that kills cells  
 
 ix
 
 
diabetes mellitus. A metabolic disorder characterized by hyperglycemia (high 
blood sugar) resulting from low levels of insulin or resistance to the effects 
of insulin 
 
doubly-labeled water. An isotope-based method of estimating total daily energy 
expenditure in free-living conditions 
 
dyslipidemia. A disorder of lipoprotein metabolism, that may be manifested by 
elevation of the total cholesterol, low-density lipoprotein cholesterol and 
the triglyceride concentrations, and a decrease in the high-density 
lipoprotein (HDL) cholesterol concentration in the blood 
 
electrocardiogram. A recording of the electrical activity of the heart 
 
endothelium. A layer of flat cells lining the closed internal spaces of the body 
such as the inside of blood vessels 
 
ergometry. The process of measuring work performed during exercise 
 
erythrocyte sedimentation rate (ESR).  A blood test that is used to monitor 
inflammation that is measured by recording the rate at which red blood 
cells sediment in a tube of normal saline over time  
 
excess CO2. The carbon dioxide exhaled due to the buffering of hydrogen ions 
during exercise above the ventilatory or anaerobic threshold 
 
fatty streaks. Lesions in the blood vessels caused by an elevated local content 
of membrane bound cholesterol and fats that represent the earliest visible 
stage of atherosclerosis  
 
fibrinogen. An acute phase protein from which a normal blood clot may 
eventually be generated 
 
foam cells. Particular cells found in the blood vessel endothelium derived from 
both macrophages (white blood cells) and smooth muscle cells which 
have accumulated and oxidized low density lipoproteins. Develop after 
fatty streaks and present in intermediate and advanced stages of 
atherosclerosis 
 
Framingham risk score. A risk calculation based on the Framingham heart 
study that evaluates a person's risk of developing coronary heart disease 
in the next 10 years 
 
 x
 
 
Friedwald equation. The most common method used for indirectly measuring a 
cholesterol component such as low density lipoprotein when the other 
major levels are already known 
 
Glycosylated hemoglobin (HbA1c). A blood test that provides an average of 
blood glucose measurements over a 2-3 month period by measuring the 
amount of sugar attached or combined with hemoglobin 
 
Hepatic. Having to do with the liver 
 
high density lipoprotein (HDL). A molecule made up of combinations of lipids 
and proteins that transports cholesterol to the liver. The higher the HDL 
cholesterol level, the lower the risk of coronary artery disease 
 
hypertension. High blood pressure 
 
Ig-G (immunoglobulin-G). The most abundant antibodies circulating in the 
blood. Involved in inflammation and the immune response  
 
IL-1 (interleukin-1). A pro-inflammatory cytokine involved in the immune 
response that increases the expression of cellular adhesion factors 
 
IL-6 (interleukin-6). A pro-inflammatory cytokine secreted by T cells and 
macrophages to stimulate and mediate the acute phase response 
 
inflammatory markers. Proteins found in the blood plasma that can be used to 
indicate an inflammatory process is taking place (C-reactive protein and 
fibrinogen) 
       
insulin sensitivity. The amount of responsiveness of the cell to insulin when it 
binds to cell receptors (to facilitate glucose uptake). Sensitivity is 
decreased when exposed to high insulin levels over long time periods and 
is the precursor of type 2 diabetes mellitus 
 
kilocalorie (kcal). A unit of measurement of the amount of energy expended or 
consumed 
 
lactate. The byproduct of energy expenditure (glycolysis) during intense 
exercise, when aerobic metabolism cannot produce ATP quickly enough 
to supply the demands of the muscle 
 
lactate threshold. Represents the highest steady-state exercising intensity that 
can be maintained for prolonged periods of time (anaerobic threshold). 
Above this point, lactate production exceeds clearance 
 
 xi
 
 
low density lipoprotein (LDL).   A molecule made up of combinations of lipids 
and proteins that carries cholesterol from the liver to other cells and 
tissues 
 
lupus erythamatosis. An autoimmune inflammatory disease of the connective 
tissues 
 
macrophages. A type of white blood cell that ingests foreign material and is a 
key player in the immune response 
 
metabolic equivalent (MET). A ratio comparing energy expenditure in the 
resting state to metabolic rate while performing some task. Commonly 
used in the context of aerobic exercise to gauge the intensity of the 
workout  
 
metabolic syndrome. A collection of commonly clustered conditions or risk 
factors that increase your chance of developing heart disease, stroke, and 
diabetes 
 
minute ventilation. The volume of air breathed each minute. A measurement 
used when measuring oxygen consumption to calculate energy 
expenditure 
 
moderate intensity. A relative measure of difficulty of physical activity, defined 
as physical activity between 3 and 6 METs 
 
modified v-slope. A method of visually determining ventilatory threshold that 
plots the minute production of carbon dioxide (VCO2) versus the minute 
utilization of oxygen (VO2) 
 
pedometer. A portable device which counts each step a person takes that is 
often used as a monitor to promote increases in physical activity 
 
physical activity (PA). Any bodily movement, planned or unplanned, produced 
by skeletal muscles that results in energy expenditure 
 
physical fitness. A set of attributes that a person has that relate to the ability to 
perform physical activity. Cardiorespiratory fitness is a type of fitness 
related to the ability to perform aerobic (endurance) activities 
 
plaques. An accumulation and swelling in artery walls that is made up of cells, or 
cell debris, that contain cholesterol, calcium and other tissue 
characterizing the atherosclerotic disease process 
 
 xii
 
 
Reebok 1-mile walk. A validated field test that allows estimation of VO2max 
using heart rate and one-mile walk time 
 
respiratory exchange ratio (RER). The ratio of carbon dioxide produced to 
oxygen consumed. Used in indirect calorimetry testing of energy 
expenditure 
 
rheumatoid arthritis. A chronic, inflammatory autoimmune disorder that causes 
the immune system to attack the joints 
 
sedentary. Activity level defined as not meeting the guidelines of 30 minutes of 
moderate level activity most days a week 
 
serum. The liquid component of blood, in which the blood cells are suspended 
 
stages of change. Also known as the transtheoretical model is a model that 
describes how changes in behavior proceed. It recognizes that a change 
in behavior occurs gradually and at an individualized rate 
 
stroke. A loss of a portion of brain function due to an interruption in the blood 
supply to part of the brain 
 
thrombosis. The obstruction of an artery or vein by a blood clot 
 
timed up and go (TUG). A validated test that combines balance, coordination 
and function most commonly used to assess fall risk. It includes a number 
of tasks such as standing from a seating position, walking, turning, 
stopping, and sitting down 
 
TNF-alpha (Tumor necrosis factor-alpha). A cytokine involved in systemic 
inflammation that stimulates the acute phase response 
 
transtheoretical model. A model that describes how changes in behavior 
proceed. It recognizes that a change in behavior occurs gradually and at 
an individualized rate 
 
type 2 diabetes mellitus. A metabolic disorder characterized by hyperglycemia 
(high blood sugar) resulting from resistance to the effects of insulin 
 
ventilatory equivalent (Ve). Term used to describe minute ventilation during 
breathing   
 
ventilatory equivalent method.  A means of visually determining ventilatory 
threshold by plotting the ratio of Ve to oxygen consumption (Ve/VO2) over 
the ratio of Ve to carbon dioxide expiration (Ve/VCO2) 
 xiii
 
 
 
ventilatory threshold. Represents the highest steady-state exercising intensity 
that can be maintained for prolonged periods of time. Indicated by the 
point where ventilation increases disproportionately to oxygen 
consumption 
 
vigorous intensity. A relative measure of difficulty of physical activity, defined 
as physical activity above 6 METs 
 
VO2max. The maximal capacity of the cardiovascular system to provide oxygen 
to muscle cells during sustained exercise generally measured in a graded 
exercise test. Reached when oxygen consumption plateaus despite 
increases in workload 
 
VO2peak. The maximum oxygen capacity attained in an incremental exercise 
test if VO2max was not reached 
 
Westergren method. Most common procedure for testing erythrocyte 
sedimentation rate  
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INTRODUCTION 
 
Cardiovascular disease (CVD) is the leading cause of death in the United 
States.1, 2 Risk factors have been established for CVD, however cardiovascular 
(CV) events like myocardial infarction and stroke often occur when CVD risk 
factor levels are within normal limits. Routine physical activity decreases CVD3, 4 
and its risk factors5-9 and improves health.2  Physical activity is inversely related 
to both CV event risk and to many of the individual CVD risk factors 
(hypertension, dyslipidemia, diabetes mellitus, obesity).2 
Despite the overwhelming evidence of the benefits of physical activity, 
more than 60% of adults in the United States are not regularly physically active 
and 25% are not active at all.2 Current physical activity recommendations are to 
accumulate 30 minutes of moderate activity most days of the week. These 
recommendations may be met through one continuous bout of exercise or 
through accumulation of several shorter bouts.2 Some programs encourage 
accumulation of physical activity throughout the day using pedometers to monitor 
physical activity. It is unclear if the intensity and duration of physical activity 
attained in these accumulated physical activity programs is sufficient to improve 
CVD risk factors.  
 The inverse relationship between physical activity and CV risk is well 
established however much dispute remains about the optimal intensity and 
duration of physical activity needed to induce health benefits and to lower CV 
risk. Because it is very difficult to obtain accurate information on habitual daily 
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activity without disrupting free living, physical activity recommendations are broad 
and the specifics of the relationship between physical activity and CV risk remain 
uncertain. Physical activity recommendations have evolved from 20 minutes of 
vigorous activity 3 days per week to at least 30 minutes of moderate activity most 
days of the week.2 These recommendations are based on epidemiological 
evidence using self-reported physical activity and cardiorespiratory fitness 
(VO2max). Self-report is a subjective assessment of physical activity and error 
rates range from 35 to 50 percent.10, 11 Although findings using cardiorespiratory 
physical fitness (VO2max) are more consistent than those using self-reported 
physical activity,2 cardiorespiratory fitness does not provide specific information 
on physical activity intensity and duration during free living. If the intensity and 
duration of physical activity best related to CV risk could be identified, perhaps 
public physical activity recommendations could be improved.   
In individuals with physical impairments, the relationship between physical 
activity and CVD risk may differ from the general population.  Residual 
neurological impairments from stroke decrease energy efficiency and increase 
energy cost of movement.  As a result a higher intensity of physical activity is 
required for mobility and routine daily activities. If stroke survivors work harder 
than individuals without impairment to perform the same task, then fitness levels 
should be higher in stroke survivors unless other parameters of physical activity 
differ. Measurement of habitual physical activity intensity and duration would 
assist in better defining the relationship between physical activity and CVD risk in 
these individuals. 
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Cardiovascular events like myocardial infarction and stroke often occur 
when CVD risk factor levels are within normal limits. Researchers have 
suggested the use of C-reactive protein (CRP) levels to improve the detection of 
CV risk and increase the prediction of CV events.12 Physical activity may also be 
inversely related to baseline levels of CRP.13 The short term effects of exercise 
on CRP levels have been investigated however the relationship between habitual 
physical activity and CRP has yet to be explored.  
By investigating the relationship between physical activity and CVD risk 
factors including CRP, additional information may be obtained on how to 
decrease CVD risk prior to a CV event and advise individuals on appropriate 
activity programs for cardiovascular health. The purpose of this collection of 
studies is to explore the association between CVD and physical activity and 
attempt to identify some specifics of this complex relationship. 
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CHAPTER 1 
REVIEW OF LITERATURE 
 
Cardiovascular Disease 
Cardiovascular disease (CVD) is the number one cause of death in the 
United States and other westernized societies and its incidence continues to 
rise.1, 2 By the year 2020, cardiovascular disease will be the leading cause of 
mortality in the world.1 Cardiovascular disease is comprised of several different 
diseases all caused by atherosclerosis. Atherosclerosis of the heart is coronary 
heart disease (CHD), of the brain is ischemic cerebrovascular disease (CVA or 
stroke) and of the extremities is peripheral vascular disease (PVD). 
Atherosclerosis is a progressive disease that is caused by an accumulation of 
plaque along the blood vessels walls (endothelium). Risk factors are common in 
children and persist into adulthood.14 Plaque buildup begins in childhood with 
fatty streaks characteristic of atherosclerosis detected as early as adolescence.14  
Much research has been done into what causes and predisposes 
individuals to developing cardiovascular disease. The Surgeon General’s report 
on the importance of physical activity for health and prevention of disease 
identified 8 risk factors for cardiovascular disease.2 They include age greater 
than 45 for males and greater than 55 for females, family history of CVD, high 
blood pressure (hypertension), diabetes mellitus, smoking, dyslipidemia 
(cholesterol imbalance), obesity and lack of physical activity. Only two of these 
factors are unchangeable, age and family history. The remaining six are 
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commonly seen together and are modifiable through lifestyle changes. The 
modifiable risk factors high cholesterol, smoking, high blood pressure, diabetes 
mellitus, obesity and physical inactivity will be briefly discussed below.  
Hypertension 
It is commonly accepted knowledge that high blood pressure is a risk 
factor for CVD. The Framingham study revealed the importance of systolic blood 
pressure on the risk of CVD.15 Isolated systolic hypertension ( > 160mmHg) was 
found to be independently predictive of CVD.16 Lowering diastolic blood pressure 
by 5 mm/Hg lowers the risk of stroke by 34% and CVD by 21% according to a 
review of the literature by MacMahon et al.17 Normal levels of blood pressure are 
systolic less than 120 mmHg and diastolic less than 80 mmHg. 
Smoking 
 Smoking is a major cause of CVD2 and is included in major risk 
assessments such as the Framingham for CVD and stroke.18 The relative risk 
(RR) of CVD for smoking 1 to 5 cigarettes per day was calculated to be 2.47 
(95% confidence interval (CI), 1.12 - 5.45) and for smoking 1 to 14 cigarettes per 
day was 3.12 compared to that of non-smoker (RR = 1.0).19, 20 In the Nurses 
Health Study, a strong dose response relationship was found between risk of 
CVD and the number of cigarettes smoked per day.21 The Surgeon General 
recommends total cessation of smoking for optimal health.20 
Dyslipidemia  
Dyslipidemia is defined as having elevated levels of total cholesterol (TC) 
and low density lipoprotein cholesterol (LDL) and depressed levels of high 
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density lipoprotein cholesterol (HDL). Normal levels of total cholesterol are less 
than 200 mg/dl, optimal LDL cholesterol levels are less than 100 mg/dl with less 
than 130 mg/dl considered normal and for HDL cholesterol levels greater than 40 
mg/dl are considered normal.22 Total cholesterol, LDL cholesterol and HDL 
cholesterol are well established as strong independent predictors of CVD.15, 22  A 
meta-analysis by the National Heart, Lung and Blood Institute disclosed that 
there is a 2 to 4 times greater CVD risk in individuals with total cholesterol 
greater that 240 mg/dl than those with levels less than 200 mg/dl.23  It was 
ascertained in the Framingham Study,15 and is now well established in the 
literature, that levels of LDL cholesterol are positively associated with the risk of 
CVD.24 The Asia Pacific Cohort Studies Collaboration compared quartiles of LDL 
cholesterol levels and found that the highest LDL cholesterol level had a relative 
risk for CVD of 1.55 (95% CI, 1.10 - 2.18) versus the lowest LDL cholesterol 
level.24 
 Levels of HDL cholesterol are inversely related to CVD incidence. Low 
concentrations of HDL cholesterol (25 mg/dl) were associated with high risk of 
CVD regardless of LDL cholesterol levels.25 The Israeli Ischemic Heart Disease 
Study compared HDL cholesterol levels to risk of ischemic stroke mortality.26 
Men in the lowest HDL cholesterol tertile had a 1.32 risk of mortality from stroke 
than those in the highest tertile of HDL cholesterol (95% CI, 0.95 to 1.83).  
Increasing HDL cholesterol levels by 1 mg/dl reduces CVD risk by 3% in women 
and 2% in men.25 
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Diabetes Mellitus 
Cardiovascular disease is the cause of death in 65% of patients with Type 
2 diabetes mellitus.18  Type 2 diabetes is characterized by insulin resistance and 
as a result, persistently high blood glucose levels (hyperglycemia). People with 
diabetes have a two to four times greater risk of developing CVD than those with 
normal fasting glucose levels.27 Preceding the onset of type 2 diabetes by years 
is a common clustering of risk factors for CVD known as metabolic syndrome. 
Metabolic syndrome is characterized by hyperglycemia, dyslipidemia, obesity, 
and hypertension among other conditions.28  The high number of CVD risk 
factors present in individuals with either metabolic syndrome or type 2 diabetes 
increases the likelihood of a CVD event. Normal fasting blood sugar values are 
less than 100 mg/dl or hemoglobin A1C levels of  4 to 6 percent.29 The HbA1c 
test, which measures the percentage of red blood cells with glucose bound to the 
hemoglobin, is considered the most objective and reliable measure of long term 
blood sugar levels.30, 31  
Obesity 
Obesity is related to increased insulin resistance (the precursor of type 2 
diabetes mellitus), blood pressure and LDL cholesterol levels.27, 28, 32 A clinical 
measurement of total obesity is body mass index (BMI) and is calculated by 
obtaining an individual’s weight in kilograms and dividing it by the square of the 
height in meters. Normal levels of BMI are considered to be less than 25 kg/m2, 
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obese greater than 30 kg/m2 and between 25 and 30 kg/m2 considered 
overweight.33  
Women with a BMI 23 to 25 kg/m2 had a 50% increase in CVD risk than 
their lower weight counterparts. Men with BMI of 25 to 29 kg/m2 were 72% more 
likely to develop CVD than men of normal weight.34, 35  Investigators in the first 
National Health and Nutrition Examination Survey (NHANES) study observed the 
relative risk for CVD of the obese group (BMI > 30 kg/m2) to be 1.28 versus 
normal weight individuals (BMI < 25 kg/m2) risk of 1.00 (95% CI 1.10 - 1.49, p < 
0.001).36 In general, as BMI increases, the relative risk of CVD increases.  
Researchers have found a connection between visceral or central 
abdominal obesity and risk of diseases such as CVD, the metabolic syndrome 
and diabetes mellitus. The two most common assessments of abdominal obesity 
include waist girth and waist to hip ratio. Two studies on Swedish men and 
women conducted in 1984 established waist to hip ratio as a cardiovascular risk 
factor.37, 38 Recommended waist to hip ratios are less than 0.88 in women and 
less than 1.0 in men.33 
Waist circumference alone, since it is one measure rather than two, has 
also been advocated as a simple measure of abdominal obesity and has been 
associated with CHD and CVD risk.39 In a 2003 study by Welborn et al. waist to 
hip ratio predicted CVD and CHD mortality better than waist circumference alone 
and both were better than BMI in both men and women but not all researchers 
agree.40, 41 It is still a common practice to use BMI as a measure of obesity and 
health risk. Most recently, Woo et al. found that the relationship of waist 
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circumference measurements with health risk is different in people over 70 years 
old.  The  accuracy of prediction of CVD was reported to be similar to BMI.40 
To evaluate obesity, the National Cholesterol Education Program (NCEP) 
advises using a waist circumference greater than 102 cm (40 inches) in men and 
greater than 88 cm (35 inches) in women however stricter guidelines have been 
recently recommended.42, 43 Bray proposes stratified risk levels of waist 
circumference using increments of ten centimeters to differentiate levels of very 
low, low, high and very high.43 Less than 70 cm for women and less than 80 cm 
for men is considered very low with 90 cm or more in women and 100 cm or 
more in men considered high.43 To best assess total and abdominal adiposity as 
well as risk of disease, researchers have suggested using both BMI and either 
waist circumference or waist to hip ratio.43, 44 
Sedentary Lifestyle  
Lack of physical activity is an important risk factor in a number of chronic 
diseases including diabetes mellitus, obesity and cardiovascular disease. Ten 
years ago it was estimated that over 50% of the population of the United States 
exercised for less than 20 minutes three times per week.45 From the 1996 
Surgeon General’s report it was estimated that in the United States, more than 
60% of adults are not regularly physically active, 25% are not active at all and 
41% of women and 35% of men engage in no physical activity outside of work.2 
In addition, nearly half of America’s youth are not vigorously active on a regular 
basis with physical activity significantly declining during adolescence.2 
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Routine physical activity decreases atherosclerosis and cardiovascular 
disease (CVD),4, 45 improves endothelial control,45 lowers blood pressure5-9 
lowers body fat and obesity,5, 9 improves insulin sensitivity,5, 34, 46 improves total 
cholesterol to HDL cholesterol ratios,5 raises HDL cholesterol levels,9 reduces 
smoking frequency9 and decreases systemic inflammation.47-49 Other benefits 
include decreased health care costs,2, 50, 51 improved mood, better quality of life 
and decreased all cause mortality.52, 53  
Physical activity is inversely related to CVD mortality risk.2, 54 A decrease 
in total energy expenditure is associated with increased CVD risk regardless of 
activity level and even after controlling for age and BMI.55 It is well established in 
the literature that routine physical activity decreases the risk of atherosclerosis 
and CVD for both older and younger adults2, 4 and even moderate levels of 
activity can be cardioprotective.2 Currently, the amount of recommended physical 
activity is 30 to 60 minutes of moderate level physical activity most if not all days 
of the week.2, 56 These levels will be described in more detail in a later section. 
Inflammation 
Atherosclerosis is a primary cause of CVD. Studies in cell biology, on 
animals, in clinical research and in epidemiology have suggested that 
atherosclerotic lesions are caused by an inflammatory response.57  Ford et al 
states that inflammation is of critical importance in the development of 
cardiovascular disease and it occurs throughout the process of atherosclerosis.58  
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Dyslipidemia 
The inflammatory response in the artery wall is initiated and perpetuated 
by high levels of LDL cholesterol in the bloodstream.1 These LDL cholesterol 
particles get deposited within the walls of the endothelium and build up over time. 
As atherosclerotic plaques build, the body attempts to process the deposits of 
oxidized low density lipoprotein cholesterol within the plaques, causing an 
inflammatory response by macrophages (a type of white blood cell) and 
perpetuation of the problem. When the macrophages accumulate too much LDL 
cholesterol, they burst becoming foam cells that remain within the endothelial 
wall. This perpetuates the inflammatory response. The continuation of this 
process results in a chronic, low grade inflammatory state.59, 60 Over the years, 
these inflamed plaques can become unstable and prone to rupture or can 
accumulate and narrow the blood vessel to a point that ischemia results in the 
tissues supplied.  
Atherosclerosis may be mediated by levels of HDL molecules in the 
blood.1 The anti-atherogenic effects of HDL come from its reversal of cholesterol 
deposition, anti-oxidative properties and anti-inflammatory role.1, 61, 62 High 
density lipoproteins assist in the transport and removal of LDL cholesterol from 
the bloodstream and the artery walls returning it to the liver for synthesis of other 
substances.62 The presence of HDL cholesterol affects expression of endothelial 
cell adhesion molecules,61 decreases the formation of oxidized LDL cholesterol 
and probably even suppresses cytokine production (e.g. c-reactive protein) in the 
liver.60 Low HDL cholesterol has been linked to higher risk of carotid artery 
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atherosclerosis, ischemic stroke and atherosclerotic progression.25 LDL 
cholesterol concentration was positively associated and HDL cholesterol was 
negatively associated with the extent of fatty streaks and raised lesions.63 
Diabetes Mellitus 
Those with type 2 diabetes and metabolic syndrome have accelerated 
plaque development and advancement of atherosclerosis. Measurement of 
atherosclerosis in patients undergoing angiography found that atherosclerosis 
was significantly higher in subjects with diabetes than in those without diabetes.64 
Aronson et al, observed the inflammatory marker C-reactive protein (CRP) to be 
lowest among those with normal fasting glucose levels [high sensitivity CRP (hs-
CRP) 0.94 + 0.11, p = 0.018] and highest in individuals diagnosed with diabetes 
(hs-CRP 1.11 + 0.13, p = 0.004).65 In addition, the investigators found mean 
levels of CRP to increase with the number of metabolic syndrome components 
present.65 Cross sectional findings confirm elevated inflammatory marker 
concentrations among individuals who have diabetes.66 
Smoking 
Smoking is known to accelerate atherosclerotic plaque development from 
the time of earliest detection to the most advanced stages of atherosclerosis.67 
Smoking was associated with more extensive fatty streaks and raised lesions in 
the abdominal aorta than not smoking.63 Grundy et al suggest that cigarette 
smoking promotes rupture and thrombosis of atherosclerotic plaques by 
destabilizing them.67 It is believed that the chemical toxins in cigarette smoke 
irritate the endothelial lining accelerating the inflammatory response. Smoking 
 13
cessation lowers the risk of atherosclerotic thrombosis by one half after one 
year.68 
Hypertension 
Inflammation is also thought to play a role in the development of hypertension or 
high blood pressure.69  The level of the inflammatory marker CRP was 
associated with increased risk of hypertension in the Women’s Health Study.69 
As atherosclerotic plaques accumulate within the blood vessel walls, the arteries 
are believed to become less compliant and unable to adjust to differing blood 
flow pressures and volumes. The presence of atherosclerotic inflammation in the 
vessels walls may reduce nitric oxide production in the endothelial cells further 
exacerbating the situation by causing vasoconstriction and increasing blood 
pressure further.70 
Obesity 
Obesity, blood pressure, diabetes and smoking were all positively 
associated with levels of inflammation as measured by CRP.57  There is a strong 
association of the inflammatory marker CRP with components of the metabolic 
syndrome, particularly obesity (r = 0.36, p < 0.0001).65 Abdominal fat often called 
central obesity, is suggested as a key regulatory site for the inflammatory 
process.65, 71  In cross sectional studies, elevation of CRP was found among 
individuals who are obese.66 A high negative correlation between weight loss and 
inflammation was observed by Heilbronn et al and by Tchernof et al in two 
separate studies of healthy obese women.71, 72 
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Inflammation and Cardiovascular Disease 
Because the development of atherosclerosis is undetectable without 
invasive procedures, scientists have searched for indicators of impending 
cardiovascular events. Many measures including LDL cholesterol and the ratio of 
total cholesterol (TC) to high density lipoprotein (HDL) have been used to monitor 
the potential for an atherosclerotic ischemic event. However, these measures 
have not proven predictive.  For example, elevated LDL cholesterol levels are 
present in only 50% of individuals who experience a cardiovascular event.73, 74 
Seventy seven percent of first cardiovascular events occurred in women with 
LDL cholesterol levels below 160 mg/dl and 46% occurred with levels below 130 
mg/dl.73 Clearly, another measure is needed to assist in predicting risk of 
cardiovascular morbidity. 
Researchers have suggested that low grade inflammation can predict 
increased risk of cardiovascular events but a causal connection has not been 
determined. Since atherosclerosis is an inflammatory process, a marker of 
inflammation is a logical choice to monitor progression. Almost every phase of 
the atherosclerotic disease process involves acute phase reactants that are 
characteristic of the inflammatory process.75  Serum markers of inflammation 
have the potential to directly or indirectly monitor atherosclerosis and perhaps to 
identify asymptomatic individuals as appropriate candidates for aggressive 
primary prevention.76, 77 Several acute phase reactants have been studied as 
potential markers of low grade inflammation including erythrocyte sedimentation 
rate (ESR), white blood cell count (WBC), fibrinogen, and CRP.78 
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Traditionally, ESR has been the standard used to monitor the 
inflammatory response. Erythrocyte sedimentation rate is a measure of the rate 
at which red blood cells (RBC) settle to the bottom of a test tube containing 
normal saline, leaving the blood serum visible above. The sedimentation rate is a 
measure of how far the top of the RBC layer has fallen in one hour.79 The 
sedimentation rate is larger with increasing levels of inflammation. Normal 
sedimentation rate, using the Westergren method, is 0 - 15 millimeters per hour 
for males and 0 - 20 millimeters per hour for females.79  
There are limitations to the use of ESR in measuring inflammation. It is 
non-specific, is altered by normal physiological occurrences, has low sensitivity 
and changes in ESR are slow and occur for variable amounts of time.80, 81  
Sedimentation rate is also affected by ambient temperature and is influenced by 
RBC disorders, pregnancy and smoking.81 For these reasons, ESR is not 
considered for use in predicting cardiovascular disease. 
Two other commonly used tests for inflammation are fibrinogen levels and 
WBC. Fibrinogen is a protein synthesized by the liver which is necessary for 
normal blood clotting. It has been established as an independent risk factor for 
cardiovascular disease.82 Normal fibrinogen levels range from 150-400 mg/dl.79 
The use of fibrinogen has not gained widespread acceptance and it only 
enhances the prediction of future events by established risk factors by 8%.83   
A WBC count can be an indicator of an infection, inflammation, or allergy. 
It is a very non-specific marker of inflammation. Normal clinical values for WBC in 
adults range from 4.5 x 106 to 11 x 106 cells/L.79 Elevations in WBC count have 
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been found to be useful in predicting coronary heart disease (CHD) mortality 
independent of other CVD risk factors.84 However WBC levels have mainly been 
studied in those with diagnosed CVD. Few studies have assessed the 
association of WBC with CVD events in apparently healthy individuals and these 
results have been mixed.84   
C – Reactive Protein 
Recently, a protein known as CRP has been investigated as a monitor of 
the acute phase inflammatory response. C-reactive protein is a protein secreted 
by the liver during a systemic acute phase response of the immune system. The 
liver produces CRP in response to secretion of tumor necrosis factor (TNF-α), 
interleukin-1 (IL-1), and interleukin-6 (IL-6) by the adipose, muscle and other 
tissue when damage is occurring.85, 86 Interleukin-6 is a major hepatic stimulant 
and levels are directly correlated with CRP levels.87 C - reactive protein is a part 
of the body’s inflammatory cascade activating neutrophils, inhibiting platelet 
aggregation and facilitating cytotoxic reactions.88 Its role is to bind with 
Immunoglobulin G (IgG) to assist in signaling further release of IL-1, neutrophils 
and macrophages and to bind with neutrophils to prevent their adhesion to 
endothelial cells.88 Through this process, CRP increases the scavenging and 
clearing of damaged cell particles. The end result is an increase in phagocytosis 
of foreign bodies.  
It has been determined that in apparently healthy individuals, CRP levels 
can predict the risk of coronary events89, 90 and risk of plaque rupture in the 
cardiovascular system.80 In several studies, CRP was a better predictor of 
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cardiovascular (CV) events than low-density lipoprotein cholesterol (LDL), 
fibrinogen or WBC count.76, 77  Plasma levels of CRP may have a higher 
prognostic value than the severity of coronary stenosis91 or LDL cholesterol 
level.92 In apparently healthy men and women, elevated levels of CRP are a 
strong predictor of cardiac events. In a study by Ridker, CRP was the single 
strongest predictor of risk and only CRP and the ratio of total cholesterol to HDL 
cholesterol were independently predictive.80 
Acute coronary syndromes may be indicated by elevated levels of CRP.  
Elevated baseline levels of CRP have been associated with sudden cardiac 
death.89 Prediction of new coronary events is consistent with assays of hs-CRP 
in patients with unstable angina93 and acute myocardial infarction.77 C-reactive 
protein is an independent risk factor of acute coronary syndromes even after 
controlling for other Framingham risk scores.73 Atherosclerotic progression is 
positively related to CRP levels. Cosin-Sales et al.94 found assays of hs-CRP 
correlate with symptoms and electrocardiogram (ECG) markers of myocardial 
ischemia. A correlation was also found between CRP and biochemical markers 
of endothelial dysfunction95 and growth of new atherosclerotic plaque.96 Elevated 
levels of CRP in patients with coronary artery disease (CAD) were associated 
with impairment of the systemic endothelial vascular activity and when CRP 
levels normalized, there was a corresponding enhancement in endothelial 
vascular activity as detected by improvements in blood flow.97  
Characteristics of C-Reactive Protein: C-reactive protein is detectable in 
the plasma and has a half life of four to seven hours. During an acute phase 
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inflammatory response, elevations of CRP begin within four to six hours, doubling 
every eight hours, with peak levels reached within 24 to 48 hours. The levels of 
CRP remain elevated while the inflammatory response persists, but decline 
rapidly once the acute response is terminated. Normal levels are restored within 
two to seven days.80, 81 These characteristics make CRP a sensitive indicator of 
inflammatory conditions.  
This was not always the case. Less than ten years ago, the standard 
assays of CRP were sensitive only in the 3 - 8 mg/L range.98 Normal 
concentration levels in the plasma are less than 0.5 mg/L with variations from 0.1 
to 10 mg/L of blood plasma considered normal.79 The previous measurement 
method was not sensitive enough to detect small fluctuations in baseline values. 
The development of a high sensitivity assay of CRP (hs-CRP) has prompted a 
reexamination of the use of this protein in determining the presence of an 
inflammatory response.  
C-reactive protein levels increase slightly with age and are easily 
measured from the blood with high sensitivity assay. High sensitivity CRP testing 
allows detection down to 0.1 mg/dl or even less.80 Levels of CRP are unaffected 
by external conditions and are much less affected by other diagnoses than are 
ESR and WBC count. The exceptions include local infection and autoimmune 
diseases. In fact, in diseases such as lupus erythematosus and rheumatoid 
arthritis, CRP is used to monitor acute exacerbations.79 
High individual variations were found in CRP levels.99 This variation can 
be around 60% and can be caused by minor trauma.100 Levels of CRP vary and 
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can increase to 17mg/L or higher with infection, muscle damage or any stimulus 
that causes inflammation. Mattusch et al. noted in a study of runners, that CRP 
levels were elevated in subjects with a knee injury and a systemic infection.48 
Within subject variation of CRP is 4 to 6 x greater than that of cholesterol.100 
Because of the fluctuation and high variability of CRP, Kushner, et al. suggest 
obtaining two separate tests to avoid false positives when infection is possible.100  
Despite the tremendous acute variations in CRP levels, long term 
circulating concentrations show consistency and these levels have been related 
to risk of cardiovascular events.12, 101 Recommendations are to use levels below 
5mg/L when using CRP as an indicator of cardiac risk.12 Levels above 5mg/L 
should be investigated for an infection or other pathology.76 Ridker et al stratified 
cardiovascular risk levels into low, moderate, and high corresponding to CRP 
levels of < 1, 1 to 3, and > 3 mg/L.102    
Exercise and CRP: The evidence supporting the benefits of physical 
activity in the prevention of cardiovascular disease is overwhelming.58 Physical 
activity is inversely linked to blood pressure, body mass index, and glucose 
intolerance, all risk factors for cardiovascular disease. In previous 
epidemiological studies, CRP levels follow the same pattern of inverse relation to 
CVD.  
The association between physical activity and reduced coronary heart 
disease risk may be mediated by the anti-inflammatory effects of regular physical 
activity.13 Investigators in several studies have shown inverse relationships 
between routine physical activity level and concentration of acute phase 
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inflammatory reactants such as fibrinogen and CRP.47-49, 103 An increase in 
leisure time physical activity has been positively correlated to lower levels of CRP 
and fibrinogen.58 Abrahamson and Vaccarino found that regular physical activity 
is independently associated with lower levels of elevated inflammation markers, 
particularly CRP.13 Geffken et al found lower levels of CRP, white blood cells and 
fibrinogen with higher levels of total physical activity.47 Rohde et al observed that 
men who exercised more than one time per week had lower levels of CRP than 
those who did not exercise.104 
Danesh et al, in 1998, reviewed previous studies of physical activity and 
CRP finding the relative risk of CVD to be 1.7 in the highest versus the lowest 
tertiles of CRP concentration (relative risk = 1.0).78 In 2000, Danesh et al 
performed a meta-analysis of CRP studies and the relative risk for CVD and this 
relative risk was 1.9 for the highest versus the lowest tertiles of CRP level 
(relative risk = 1.0).101 The strongest associations of CRP and CVD were found 
with both smoking and BMI with an odds ratio for CHD of 2.13 after adjustments 
versus the relative risk of 1.0 in the lowest CRP category.101 
C-reactive protein may be a valid way of monitoring tissue inflammation 
and damage at the systemic level.105 It appears that sporadic exercise 
temporarily increases the inflammatory response while regular exercise lowers 
it.106 Acute elevation of inflammatory markers has been observed  and 
associated with vigorous activity, most likely caused by muscle and joint 
inflammation.48, 107-109 High intensity, short duration exercise may cause more 
inflammation than lower intensity, longer duration exercise.110 Meyer et al 
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reported that repeated short bouts of cycle ergometry caused a greater acute 
phase response than a single longer bout of cycling exercise.111  
When tissue damage or acute inflammation occurs, regardless of the 
cause, changes in CRP levels are not immediate. C-reactive protein levels begin 
rising between 4 and 8 hours after activity initiation and remain above baseline at 
24 hours.112 Bench stepping for 40 minutes revealed CRP unchanged 
immediately post exercise. However, at one-day post exercise, CRP levels were 
at their highest at 3.9 mg/L returning to basal levels 2-3 days post exercise.113 
The effect of exercise on CRP seems to mimic that of an inflammatory response 
to an infection or injury.  
CRP response to exercise may be attenuated with daily high intensity 
exercise. Trained athletes may have a diminished acute phase reaction and a 
suppressed inflammatory response due to adaptation to a regular exercise 
routine.48, 106 Regular exercise may also decrease baseline levels of CRP.108 
Adaptation of the inflammatory response may occur in trained athletes105 if the 
athletes train regularly and avoid over-training. High sensitivity assay of CRP 
under resting conditions taken before and after 9 months of training fell from 1.19 
mg/L to 0.82 mg/L as the mean distance run per week increased from 31 + 9 km 
to 53 +15 km.48 Regular training lowered CRP in both wrestlers and rowers.99 
Increases in endurance exercise reduced baseline levels of CRP after 12 weeks 
in patients enrolled in cardiac rehabilitation.114, 115 No acute phase responses 
were observed after training in elite female netball and soccer teams.109 
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Intensity, duration and type of exercise affect the degree of the 
inflammatory response.  In contrast to the above investigations, researchers 
found significant elevations of plasma CRP levels during and after competitive 
exercise in studies involving marathoners, ultra-triathlon and triathletes. During 
an ultra-triathlon of 48 hours, CRP levels continually increased throughout the 
race116 and were elevated after a 56 km footrace.117 Male marathoners had 
increases in plasma levels of CRP at 16 hours after racing. Levels of IL-6, the 
stimulator of CRP, were increased immediately post exercise and at 1-hour post 
exercise.112 In a canoe, cycle and running triathlon, CRP levels increased 300% 
within 24 hours of the race.118 Return to baseline levels may occur within 2 to 7 
days depending on intensity of exercise, health and fitness level.80, 81 The 
differences in acute phase responses may be due to the excess stress and 
damage caused by the vastly different levels of intensity and distance between 
training for races and the actual competition. 
 Eccentric exercise is known to cause more tissue damage than 
concentric and may therefore cause a greater inflammatory response.108, 119 
Among athletes, female and male swimmers and male rowers had lower CRP 
baselines than control subjects, cyclists, runners and soccer players.108 
Swimmers and rowers training at least four days per week had significantly lower 
baseline CRP values than untrained controls. Both swimming and rowing involve 
minimal eccentric exercise. Values for the control group were 0.5 mg/ml, 
compared to the lower values of swimmers at 0.10 mg/ml (p< 0.001) and of 
rowers at 0.26 mg/ml (p < 0.01).49 In the same study, athletes in sports involving 
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eccentric activities (runners, cyclists and soccer players) had baseline CRP 
values that did not differ from that of control subjects.  
When looking at the NHANES study that surveyed activity level of 17 to 65 
year olds, regular jogging and aerobic dancing but not cycling, swimming or 
weight lifting were associated with statistically significantly lower levels of 
CRP.108 This is similar to the findings of Tanasescu et al. that walking, running 
and weight training lowered the risk of CV mortality but cycling and swimming did 
not.120 These results contrast those of King et al.108 It is unclear what intensity 
levels were performed in the latter 2 studies using physical activity 
questionnaires. 
Higher levels of activity and fitness seem to correspond to lower baseline 
levels of CRP. In general, CRP levels are inversely related to average daily 
physical activity. Elevated CRP levels were found in 21 sedentary, 17 lightly, 13 
moderately and 8 vigorously physically-active study participants.58 Across fitness 
levels there is an inverse relationship with CRP.121, 122 However, the acute effect 
of exercise on CRP levels appears to vary with the type of activity, intensity level, 
individual fitness level and duration of activity bout.76 
  Summary of CRP: The inflammatory marker known as CRP may be useful 
in conjunction with other tests such as LDL cholesterol level in detecting risk for 
cardiovascular disease in at risk patients. Ridker et al recommend the use of 
CRP in conjunction with LDL cholesterol levels to assist in improving prediction of 
CVD events such as myocardial infarction and stroke.73 In athletes, the levels of 
CRP tend to vary with level of tissue damage during exercise but levels attenuate 
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as the body adapts to a training program. Overall, baseline levels of CRP 
decrease with increasing levels of physical activity indicating a lower risk for 
CVD.  
Physical Activity 
The terms physical activity and physical fitness are often used 
interchangeably in conversational language. Researchers recognize the two 
terms separately. Physical activity is defined as “any bodily movement, planned 
or unplanned, produced by skeletal muscles that results in energy expenditure.”2  
Exercise is a subset of physical activity and refers to “planned, structured and 
repetitive bodily movement done to improve or maintain one or more of the 
components of physical fitness.”2 
Physical fitness is “a set of attributes that a person has that relate to the 
ability to perform physical activity.”2 It is the ability to perform daily tasks with 
vigor and alertness, without undue fatigue and with ample energy to enjoy leisure 
time pursuits. The definition of physical fitness can differ between athletic 
performance and health fitness. Components of health fitness include 
cardiorespiratory endurance, muscular strength and endurance, flexibility and 
body composition.33 The American College of Sports Medicine (ACSM) reports 
that “cardiorespiratory physical fitness is strongly associated with health benefits 
in the general population”56 and is directly related to habitual physical activity.2, 
122 Findings relating cardiovascular disease and health benefits of activity are 
more consistent for studies using cardiorespiratory fitness than using reported 
physical activity.2 Cardiorespiratory or aerobic fitness will henceforth be referred 
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to in this paper as physical fitness. Both physical activity or the accumulation of 
movement over a specific time period, and physical fitness or the average of the 
daily activity intensity accumulated, have been used to quantify amount and 
intensity of habitual physical activity or energy expenditure.  
Quantification Issues 
Understanding the basic characteristics of habitual activity is important to 
understanding the relationship of physical activity (PA) to chronic diseases such 
as cardiovascular disease.123 Yet there is no standardization of measurement 
methods of physical activity in the literature.124  This is because the quantification 
of energy expenditure and habitual physical activity is complex. It is difficult to 
accurately and objectively measure the total amount of physical activity over the 
course of the day without disrupting the normal course of activities known as 
“free living.”2  Direct measurement of physical activity is possible using 
techniques such as direct calorimetry, expired gas analysis or doubly labeled 
water but these techniques are difficult and often expensive.125 Therefore, direct 
measurement of physical activity is primarily used in smaller scale studies. 
Indirect measures are more practical in larger studies and many indirect 
measurement techniques have been correlated to daily physical activity.  
There are two predominantly used methods to quantify amount of regular 
activity when studying all-cause mortality and cardiovascular disease mortality. 
They are cardiovascular physical fitness (fitness level) and self-reported physical 
activity. Self-reported physical activity is measured using a leisure time physical 
activity (LTPA) questionnaire.124 The main differences are that physical fitness is 
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an objective measure of habitual physical activity and the LTPA questionnaire is 
a subjective estimation of physical activity over time. 
Physical Activity Recommendations 
In 1996, the Centers for Disease Control published the Surgeon General’s 
report2 on the importance of physical activity for health and for the prevention of 
disease. This report identified risk factors for cardiovascular disease. They 
include age greater than 45 for males and greater than 55 for females, family 
history of CVD, high blood pressure (hypertension), diabetes mellitus or insulin 
resistance, smoking, high cholesterol (dyslipidemia), obesity and lack of physical 
activity.  
Prior to 1996, recommendations of the American College of Sports 
Medicine (ASCM)33, 56 and Centers for Disease Control (CDC)2, 56 suggested that 
vigorous activity levels of 15 to 60 minutes duration, 3 to 5 days per week were 
necessary for health benefits.2, 56 These recommendations were based on 
analysis of the lifestyles of young, healthy individuals.  In the early 1990’s, the 
Centers for Disease Control examined the evidence collected on physical activity 
in middle aged and older adults and the results were incorporated into the 1996 
report, “Physical Activity and Health; A Report of the Surgeon General.”2  
The 1996 Surgeon General’s report established new guidelines for 
physical activity. To decrease risk of both CVD and all-cause mortality, “at least 
thirty minutes of moderate level physical activity on most, preferably all, days of 
the week” is recommended. Moderate activity is defined as 3 to 6 metabolic 
equivalents (METs), with 3 METs being similar to the level of a brisk walk.2 The 
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1996 Surgeon General’s report was based on the results of several large cohort 
studies including the Framingham Heart,126 the Harvard Health127 and the 
Aerobic Center studies.124, 128-130 These studies either used self-reported physical 
activity or physical fitness levels as measures of physical activity.  
Self-reported Physical Activity: There were seven major studies that 
examined the relationship of self-reported physical activity and CVD mortality.2 
The Framingham study related self-reported activity levels to cardiovascular 
disease mortality in 4000 men and women.126 This study identified and 
established many of the current risk factors for heart disease including physical 
inactivity, smoking, hypertension, hyperlipidemia, insulin resistance and age. In 
the Harvard health study, Paffenbarger et al. observed self-reported activity of 
Harvard alumni and found that smoking, and physical inactivity were related to 
higher mortality rates from CVD.127 A trend of decreased death with increased 
self-reported activity level was also observed for both cardiovascular and all-
cause mortality.  
Cardiorespiratory Physical Fitness: Findings relating physical activity to 
CVD are even more consistent for studies using physical fitness than using self-
reported physical activity.2 Five cohort studies related physical fitness to CVD 
mortality.2 Blair et al confirmed that there is an inverse relationship between 
cardiorespiratory fitness level and both CVD and all-cause mortality.124, 128-130 
From the collected evidence, a dose-response relationship is suggested between 
physical activity and risk of both CVD and all-cause mortality.124 There were 
greater benefits for those that were the most active however, it was concluded 
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that even moderate intensity physical activity can significantly effect 
cardiorespiratory performance and provide health-related benefits.2  
Despite these landmark studies, there are many questions that remain 
unanswered. Exercising at or above the Surgeon General’s recommendation is 
likely to decrease all cause mortality but the best method of acquiring this activity 
is not yet clear.124, 131 The optimal type, intensity, frequency, duration or bouts by 
which this activity should be accumulated has not yet been established.124 One of 
the difficulties encountered in establishing optimal activity for prevention of 
cardiovascular disease is in the measurement of physical activity during free 
living or unrestricted movement during daily life. 
Measurement of Physical Activity  
Self-Report: Physical activity is the total amount of movement performed 
by an individual above the basal metabolic rate (BMR) which is the minimal 
energy expenditure necessary to survive. Physical activity is most often 
assessed in epidemiological studies through self-report activity surveys. These 
are questionnaires that rely on recall of LTPA for various time periods ranging 
from one day to six months. These assessments are easily administered and 
user-friendly however questionnaires are subjective and depend on an 
individual’s recall and perception of activities.124 Analyses of self-reported activity 
reveal considerable variability and only moderate external validity.2  Estimated 
error associated with LTPA questionnaires ranges from 35 to 50 percent 
depending on the populations studied.10, 11 
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Other indirect and objective methods of measuring physical activity use 
heart rate monitors or motion detectors such as pedometers and accelerometers. 
These devices allow estimation of physical activity levels that are less accurate 
than direct methods while still providing an objective measurement of physical 
activity for longer periods at reasonable cost.  
Pedometer Studies: Pedometers are devices that measure vertical 
excursion at the hip during walking giving raw data in total number of steps. 
Because many daily activities incorporate walking, this information can also be 
used to monitor free living. Data provided by the pedometer not only consists of 
total steps, but calculations of distance traveled and estimates of energy 
expenditure can also be obtained.132 During controlled walking and running, 
correlations of r = 0.84 to r = 0.93 of pedometers with accelerometers have been 
observed.133 Some health promotion programs, such as 10,000 steps and Active 
Living, Everyday®, promote the use of pedometers to monitor daily activity levels 
and to provide both feedback and goal-oriented motivation to increase physical 
activity levels. Benefits of using these devices include their low cost, 
unobtrusiveness and ease of both use and output interpretation.132, 134 
Pedometers range in cost from 10 to 50 US dollars.135 
Sensitivity of pedometers can differ by brand so some care must be taken 
if using for research purposes.136 Particularly at slow walking speeds (less than 
2.4 miles per hour), many of the pedometers underestimated actual steps and 
distance.136 In distance calculation, some of the error can be attributed to stride 
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length as well as step count. Stride length tends to vary with walking speed 
however only one stride length setting is permitted in the pedometer memory. 
Pedometers are designed to capture ambulatory activities and because of 
this, one of the major limitations of the device is the inability to capture common 
physical activities such as bicycling, swimming and weight lifting.132 During uphill 
and downhill walking, pedometers may not measure number of steps with 
accuracy.136 Pedometers will tend to underestimate the energy cost of most 
lifestyle activities including stair climbing, and those involving upper extremity 
activity.136 Pedometers are best at capturing steps, less accurate in calculating 
distance and least accurate at determining energy expenditure.134 Despite the 
limitations mentioned, pedometers are useful in capturing ambulatory activity 
throughout the day and can provide an extremely useful and objective gauge of 
an individual’s overall ambulatory activity levels at low cost with little 
inconvenience.136 With researchers finding recall of non-structured moderate 
level activities to be less accurate than more structured or vigorous exercise, 
pedometers can be beneficial to objectively measure activity whether incidental 
or intentional and to provide feedback to improve motivation.134 
Accelerometers: Activity monitors or accelerometers are a commonly used 
method of assessing physical activity during free-living. Accelerometers are 
recognized as valid tools for assessing free living and have gained acceptance 
as, “Possibly the most effective method of obtaining objective information about 
physical activity level.”137 These monitors allow for free-living without the 
constraints induced by direct calorimetry methods. Though the monitors are less 
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accurate than doubly labeled water procedures or direct calorimetry methods, 
activity monitors provide a convenient, simple and efficient method of objectively 
quantifying physical activity over long periods of time at much lower cost.11, 137 
Accelerometers eliminate some of the inherent limitations of self-report 
questionnaires including subjectivity of frequency, intensity and duration while 
still allowing for estimation of total energy expenditure.138, 139 They are more 
objective and precise than pedometers or LPTA questionnaires, and unlike LPTA 
questionnaires are free from random or systematic error due to recall or self 
report.10, 140, 141  
Accelerometers measure motion in three orthogonal planes of movement 
and are therefore sensitive to non-ambulatory movements.133 They provide a 
standardized description of free-living physical activity in real time including 
intensity, duration and frequency.138 They can record and store activity data for 
extended periods and have adjustable epochs (time periods for which activity is 
averaged).123, 142 A reliability study of four different accelerometers to actual 
energy expenditure revealed interclass correlation coefficients ranging from 0.62 
to 0.80.137 Comparisons of other studies showed prediction equations with 
correlations up to 0.89 when looking at only walking and running activities138 and 
up to 0.99 with level walking alone regardless of walking speed.133, 143 The device 
discriminated among subjects in three categories, sedentary, moderately active 
and active and between specific activities (such as walking, cycling and jogging) 
and those with varying intensities light, moderate, and intense.144 The devices 
tend to overestimate activity associated with excessive vibration such as riding in 
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a motor vehicle or operating machinery133 and are somewhat limited in accurate 
assessment of activities such as cycling and swimming due to the minimal 
acceleration of the center of gravity when monitoring at the hip or low back.123, 138, 
142 Accelerometers costs range from 50 up to 400 US dollars.135  
Accelerometers and pedometers are objective measures of physical 
activity that can assist with determining which individuals are meeting or 
exceeding the recommended minimal levels of physical activity. Each device has 
its limitations and advantages. The high correlations seen between the 
accelerometer and pedometer by Tudor-Locke et al.145  and Schneider et al.134 (r 
= 0.80 - 0.86) would allow either device to be utilized particularly if only relative 
values are required for analysis. 
Physical Fitness: Another method used for measuring physical activity is 
fitness level. Cardiorespiratory physical fitness is directly related to habitual 
physical activity 2, 122 and is the type of fitness most strongly associated with 
health benefits in the general population.56 The benefit of using fitness as a 
measure of physical activity is that through objective measurement, there is a 
reduction of the bias that results from self-reported activity levels such as LTPA 
questionnaires.122 In fact, findings are more consistent for studies using fitness 
than using physical activity.2 
The standard for fitness measurement has traditionally been VO2max. 
This is defined as, “The maximal capacity of the cardiovascular system to provide 
oxygen to muscle cells during sustained exercise.”146  It is usually determined 
using an incremental exercise protocol on a motorized treadmill or bicycle 
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ergometer.147  Large cohort studies have examined VO2max, relating it inversely 
with all-cause and CVD mortality.128, 130 The assessment of VO2max requires 
exercise to a maximal volitional exertion level and a high level of motivation by 
the subject.148 This intensity of exercise can be sustained for less than one 
minute.147 Specialized equipment is necessary to measure expiratory gases and 
it is difficult even for the best athletes to perform well because it requires 
exercising to exhaustion.147 Athletes and trained subjects may be able to tolerate 
this maximum intensity effort however for sedentary individuals, those with health 
problems and those at risk for cardiovascular disease, this measure is potentially 
dangerous and generally not well tolerated.148 Because people spend the 
majority of their time in submaximal levels of activity, a method that quantifies the 
capacity of an individual to exercise for longer periods of time is more appropriate 
for the general population.147 There are two such measurements that exist, 
lactate threshold (LT) and ventilatory threshold (VT). 
Chemistry of exercise: During exercise, lactate (La-) and hydrogen ions 
(H+) are produced by the muscle. These products are often utilized within the 
muscle as energy sources for the Krebs cycle and glycolysis. Excess La- and H+ 
ions are released from the muscle into the bloodstream.  
Sodium bicarbonate (Na HCO3) is present in the bloodstream. Sodium 
bicarbonate dissociates into Na++ HCO3-.  The Na+ ions buffer La- and the HCO3- 
buffers the H+. In this form, both the H+ and the La- can be transported through 
the bloodstream. The excess La- is used by the heart, the brain, and muscles in 
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other parts of the body as an energy source. The liver also takes up La- using it 
to produce glucose through the process of gluconeogenesis.149 
The H+ ions are buffered by the bicarbonate HCO3- demonstrated by the 
equation: H2O +CO2 = H2CO3 = H+ + HCO3-. The direction of this equation is 
driven by the acidity or the amount of H+ ions present. If there are more H+ ions 
being produced, the equation is driven to the left, with more H2O +CO2 the result. 
The extra CO2 causes an increase in the partial pressure of CO2 in the blood. 
This excess is eliminated through formation of additional HCO3- and through gas 
exchange in the lungs via lung ventilation. The respiratory exchange ratio (RER) 
is the ratio of the volume of carbon dioxide (VCO2) expired to the volume of 
oxygen (VO2) consumed. Normal values during steady state exercise vary 
between 0.7 and 1.0.147, 150 While in steady state exercise, the production rates of 
La-, H+ and CO2 are equal to their elimination rates. Throughout steady state 
exercise, ventilation increases linearly with both oxygen consumption and carbon 
dioxide production. The term ventilatory equivalent (Ve) is used to describe 
minute ventilation and is generally used in a ratio of Ve to oxygen consumption 
(Ve/VO2) or to carbon dioxide expiration (Ve/VCO2).150 During steady state, 
Ve/VO2 averages between 20 and 25 liters of air per liter of O2 consumed.147, 150  
When the body exceeds its aerobic capacity, both La- and H+ accumulate 
in the bloodstream and surpass the system’s utilization of La- and buffering 
capacity of H+ ions. The buffered H+ is combined with bicarbonate and expired 
into the air as excess CO2. When the production of La- exceeds the buffering 
capability and uptake/utilization, the LT is reached.151 The LT can also be defined 
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as the maximum intensity at which a steady state of exercise can be 
maintained.33, 147  
Above LT, acidosis develops accompanied by increases in the partial 
pressure of CO2. The increase in acidosis causes ventilation to increase to 
facilitate O2 and CO2 exchange helping rid the body of the excess CO2.  As the 
intensity of exercise continues to increase, the production of H+ ions exceeds the 
body’s ability to buffer the ions and ventilation starts to increase in a non-linear 
fashion. This point where ventilation deviates from the progressive linear 
increase of steady state is called the ventilatory threshold (VT).152  
When below VT, an individual can achieve a steady state of activity where 
not only heart rate but VO2 and VCO2 expiratory gases remain constant. When 
above VT, the kinetics of CO2 change because CO2 is not being produced solely 
as a consequence of aerobic metabolism. Additional carbon dioxide is produced 
and expired when the acid buffered by the bicarbonate system exceeds the 
capacity of the system.153 The excess CO2 causes the respiratory exchange ratio 
(RER) to increase above 1.0.147, 150 As a result, there is an increase in CO2 
without an increase in O2 at VT. The accumulation of H+ ions lowers the blood pH 
altering energy production and muscle contraction.151 
The accurate measurement of LT requires an invasive procedure to obtain 
samples of blood to measure levels of lactate. These measures must be 
repeated at least once every minute. Because of frequent sampling and the 
variation of blood lactate concentrations depending on sample site, the standard 
procedure is to use either central venous or arterial samples through the use of a 
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catheter line. Medical supervision is necessary and there is a potential risk for 
complications particularly with sampling centrally.147  
Ventilatory threshold is considered an indirect measure of LT.154, 155 It is a 
noninvasive method of determining the LT by plotting ventilation and respiratory 
data. The LT and the ventilatory threshold are known to occur at similar time 
periods however they are not directly linked.151 When the metabolic needs for 
oxygen in the muscle exceed the capacity of the cardiopulmonary system to 
supply them, there is a sudden increase in anaerobic metabolism and lactate is 
formed.151 The level of activity at VT corresponds with intensity that causes the 
first rise in blood lactate levels.152 Strong relationships have been established 
between VT and LT with high correlations between LT and VT found in studies 
by Davis in 1976 and Caiozzo in 1982 (r = 0.88 to 0.95).154, 155 High correlations 
with LT have been found for V-slope, Excess CO2 (Ex CO2) and ventilatory 
equivalent, (all measures of ventilatory threshold) with correlation coefficients at 
0.81, 0.94 and 0.87 respectively.156 Using a combination of the above methods to 
determine VT, Gaskill et al. (2001) found high correlations with LT (r2 = 
0.9850).156  
It has become more common to use VT as a basis for determining fitness 
level and exercise intensity.156 Researchers have demonstrated that VT is an 
accurate method of determining fitness level and have shown a positive 
correlation between daily physical activity intensity and VT.156 Scientists from the 
HERITAGE Family study suggest, “VT is more related to self-reported activity 
levels, activity level during activities of daily living, intensity of prescribed physical 
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work and maximal sustainable work than is VO2max.”156 There are several 
different methods of determining VT including ventilatory equivalents (VE), 
excess CO2 (Ex CO2), and modified V-slope (V-slope). All three methods use 
graphing techniques and require determination of the first non-linear change or 
breakpoint in the slope. These methods are described below. 
The ventilatory equivalent method plots Ve/VCO2 and Ve/VO2 previously 
defined as the volume of air ventilated divided by the volume of CO2 expired 
(Ve/VCO2) and O2 consumed (Ve/VO2) (see figure 1).  This method requires 
locating the intensity of activity that causes the first rise in the ventilatory 
equivalent of oxygen (Ve/VO2) without a concurrent rise in the ventilatory 
equivalent of carbon dioxide (Ve/VCO2). This method is dependent on the 
ventilatory response to exercise.157  Caiozzo et al. recommended VE/ VO2 as the 
method of determining VT that was best correlated with La- (r = 0.93, r2 = 0.77 to 
0.92).155, 156 
The excess carbon dioxide method determines the intensity of activity that 
causes an increase from steady state production of CO2 to an excess of CO2 
(see figure 1). Excess CO2 is calculated as ((VCO2/VO2 ) - VCO2).158 This method 
relies on the detection of excess CO2 expired when threshold is reached and has 
correlational values that explain 82 to 94 percent of the variance (r2 = 0.82 to 
0.94).156 
Figure 1  Visual Determination of Ventilatory Threshold 
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Figure 1: Visual determination of ventilatory threshold (VT) using three methods. 
The arrows designate the choice of VT in these sample graphs from one subject. 
A. Ventilatory equivalence method: VT is chosen at the time corresponding to the 
first sustained rise in the ventilatory equivalent of O2 (VE/VO2) without a 
concurrent rise in the ventilatory equivalent of CO2 (VE/VC O2). B. Excess CO2 
method: VT is chosen at the time corresponding to the first sustained rise in 
excess CO2. C. Modified V-slope method: VT is chosen at the VO2 value 
corresponding with the increase in slope of VO2 -VCO2 plot.  From: Gaskill SE, 
Ruby BC, Walker A, Sanchez O, Serfass R, Leon A. Medicine and Science in 
Sports and Exercise, 2001;33(11):1841-1848. 
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 The V-slope method plots the minute production of carbon dioxide (VCO2) 
versus the minute utilization of oxygen (VO2). The V-slope method is dependent 
on proton buffering capability of the bicarbonate system. There is a breakpoint or 
change in slope that occurs on the graph of VCO2 versus the VO2 that 
corresponds with the time at which VCO2 rate surpasses VO2 rate157 or when the 
slope increases from less than one to greater than one (see figure 1).159 Again, a 
change in CO2 expiration is being detected. This method was determined to be a 
sensitive index and was the most reliable detector of LT with r2 values ranging 
from 0.81 to 0.95.156, 160, 161 
Though the separate analysis of each method reports good correlations 
with LT, the combination of the three methods appears to have even greater 
accuracy. The combining of the three methods (V-slope, Ex CO2 and Ve/VCO2) 
to determine VT was examined by Gaskill et al. The combination of the three 
methods was shown to have high correlation with LT across fitness levels in 
adults (r = 0.95 to 0.98).156 Correlations of RER to VT have been moderate (r = 
0.73 to 0.86) however monitoring changes in RER in real time can assist with 
approximating VT during exercise testing and can be used as a confirmation of 
VT attainment.157  
Fitness Level and Cardiovascular Disease 
Fitness levels have been shown to be a strong predictor of CVD 
mortality.129, 162  When fitness levels were divided into quintiles, being in the 
lowest fifth of fitness was an important precursor of CVD mortality.52 Being the 
least fit is one of the stronger predictors of all cause mortality in both men and 
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women comparable to smoking, and stronger than blood pressure or 
cholesterol.129 Even in those who have other risk factors for cardiovascular 
disease, higher levels of fitness provide protection from CVD mortality.52, 163  
There is evidence that the relationship between fitness and both all-cause 
and CVD mortality is one of dose-response.124 There is a strong inverse 
relationship present for both men and women between fitness level and CVD 
mortality.129, 164 Inverse dose-response relationships are strongest for all-cause 
and cardiovascular mortality; however, lower incidence rates for hypertension 
(high blood pressure), obesity, and type 2 diabetes mellitus have also been 
consistently reported in the literature.56 In general there is a stratification of 
mortality from unfit to fit.165, 166  
Those who were sedentary and became fit improved their cardiac risk 
profile, and had decreased mortality rates. Their risk was significantly reduced 
approaching that of a moderately fit individual.165, 167 Beginning and maintaining 
an exercise program later in life was more beneficial than starting as an athlete 
and becoming sedentary.167 This held true in the Nurses Health study34 and in 
the Aerobics Center Longitudinal study.168 Unfit men who became fit had an 
estimated relative risk (rr) for CVD mortality of 0.52 compared with those who 
remained unfit (rr = 1.0).168 
There is an association between usual habitual physical activity and 
aerobic fitness and risk for chronic disease.45 It would be useful to have a method 
of measuring an individual’s activity level without disrupting free living. Ventilatory 
threshold is a better marker of habitual physical activity than VO2max.152 
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Ventilatory threshold has been shown to be related to daily activity levels and an 
accurate measure of chronic activity levels by both Tamai169 and the HERITAGE 
Family study.156 Tamai et al reported that VT was correlated with discretionary 
physical activity (r = 0.80), work hours per month (r = 0.71) and exercise hours 
per month (r = 0.67).169 Participants in the HERITAGE family study who were 
sedentary had a mean baseline oxygen consumption at VT (VO2vt) of 17.7 + 4.1 
ml/kg/min.152 These outcomes are consistent with previous researcher’s results 
that activities of daily living require a VO2 of 14 to 21 ml/kg/min (4 and 6 
METS).169 Values for VT in athletes were maintained between 42 and 47 
ml/kg/min over 15 years of training.169 
The relationship between habitual physical activity and fitness is further 
substantiated when looking at training studies. Ventilatory threshold is a better 
predictor of performance in endurance events than VO2max.170 Greater 
improvements in VO2vt are seen when training levels are set relative to VT. 
Participants in the HERITAGE family study who exercised at levels above VT 
had greater improvements in submaximal fitness than those who exercised at 
levels at or below VT.156 Training at levels just above threshold increased VO2vt 
by 48 percent in study by Henritze et al.171 Elite athletes routinely use VO2 as an 
assessment of training intensity and effectiveness152 but may be better served 
using VT as an indicator particularly for endurance activities. 
Subjective Measurement of Ventilatory Threshold: The Borg scale rating 
of perceived exertion (RPE) was developed to subjectively assess intensity of 
exercise or physical activity.172 This method can also be used to determine 
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ventilatory threshold (VT) and the rate of lactate accumulation.56 The RPE scale 
can be useful in rapidly determining VT without expensive equipment such as a 
metabolic cart. Researchers have established that RPE is of practical value to 
prescribe exercise training intensities in sedentary adults, recreational athletes 
and elite athletes.173 Swaine et al observed that regardless of habitual exercise 
level and training mode, subjects selected a common intensity of effort that was 
compatible with the described RPE.174 Feriche et al found no significant 
differences between mean values of VT and RPE at threshold and recommend a 
fixed value (12 - 13) of the RPE scale to detect the exercise intensity 
corresponding to VT.175  
Physical Activity and Cardiovascular Risk 
Analysis of the risk of cardiovascular disease suggests that physical 
activity, most commonly assessed using a LTPA questionnaire, is inversely 
related to mortality and morbidity in both men and women.176 Based on leisure 
time physical activity, median relative risk for mortality was 0.66 (95% CI) for the 
most active, fit women versus their sedentary counterparts who had a relative 
risk of 1.0. This is similar to the 0.70 (95% CI) median relative risk found for men 
in the same fitness levels.177 Researchers found that women also had 
stratification of mortality risk, from lowest to highest: active, inactive to active, 
sedentary.165 Haapanen et al observed that total amount of activity was related to 
lower CVD risk in men, but not in women.46  An inverse linear relationship was 
found between running amount and CVD risk. 178   
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In a meta-analysis of physical activity and CVD disease, Lee noted that 33 
out of 44 studies showed an inverse relationship between amount of physical 
activity and all cause mortality.179 Five out of ten studies had a minimal threshold 
of physical activity that decreased mortality.179 These numbers are explained in 
the following section. 
It is important to note that physical activity must be current and persistent 
to produce the desired health benefits including cardiovascular protection.5, 14 
Only ongoing or current exercise, protected against CVD.167 Increasing activity 
from sedentary to high levels in mid to advanced age was better than being an 
athlete and becoming sedentary with no vigorous activity later in life. These 
physically active people had a 62% lower risk than those who became 
sedentary.167  
Physical Activity Parameters 
The Surgeon General’s report recommends at least 30 minutes of 
moderate level physical activity, most if not all days per week. This is the 
equivalent of 2 to 2.5 hours per week, or if walking, approximately 9 miles per 
week when exercise is accumulated. Does activity have to be spread throughout 
the week? “Weekend warriors” are described as those individuals who are 
sedentary during the week obtaining the majority of their physical activity during a 
two or three day period (Friday, Saturday, Sunday). Weekend warriors who 
expended great amounts of energy in only two days had a similar reduction in 
risk of CVD mortality as those who were active on a daily basis.176 However, 
those weekend warriors with CVD risk factors such as high blood pressure, 
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obesity or smoking needed higher overall activity levels than their healthy 
counterparts to provide protection against CVD mortality.176  
Researchers in several studies found that there was a threshold of 
minimal fitness or physical activity necessary for protection from CVD 
mortality.179 For maintenance of CVD health, expenditure of at least 1000 
additional kilocalories per week is necessary  and seemed to be sufficient to 
avert premature mortality.176 Expending greater than 2000 additional kilocalories 
per week was the most beneficial for reducing risk factors of heart disease.167, 177, 
180 
In intervention studies, investigators have found that there was a thirty to 
forty percent decrease in CVD mortality in those who began brisk walking 2.5 to 
3 hours/week34, 181 or who accumulated 1.5 hours of vigorous activity per week.34 
In the Honolulu heart study, those who walked 1.5 miles per day had 50% lower 
risk of CVD than those who walked less than 0.25 mile/day.182 A meta-analysis of 
physical activity and relative risk revealed that women who walked more than 
one hour per week had a relative risk of 0.80 (95% CI = 0.74 -0.87) compared to 
those who were sedentary (RR = 1.0).183 In general, those who met or exceeded 
the Surgeon General’s recommendations had the greatest reduction in CVD risk 
however effects were seen in those with lesser amounts of daily and 
accumulated exercise. 
Intensity: Based on previous research, investigators suggest that 
moderate levels of physical activity are sufficient to provide protective effects 
against CVD mortality with more intense levels providing greater protection.167, 
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184-186 Brisk walking and vigorous exercise had similar effects on reduction of 
incidence of coronary events in women in the prospective Nurses Health Study.34 
In general the inverse relationship with CVD held for all activity levels. However, 
all the evidence does not agree. Recently, Yu et al recommended at least eight 
minutes of daily, high intensity activity for protection from CVD mortality. 
Acquiring only moderate levels of activity did not appear to provide protection.187  
Determination of intensity level is generally based on an absolute scale of 
metabolic equivalents. These metabolic equivalents for specific activities are 
based on energy requirements for a healthy, fit individual and vary greatly in 
those with lower fitness level. Lee et al examined rate of perceived exertion as a 
measure of relative intensity and found an inverse association of relative intensity 
of physical activity to risk of CHD.188 The highest intensity category had a 0.72 
relative risk (CI = 0.52 to 1.0) while the moderate category was 0.69 (CI = 0.51 to 
0.94). Assessing relative intensity using RPE allows scientists to generalize 
intensity from the most fit to those with physical impairments that may 
necessitate much higher energy expenditure for the same activity.183 
C-Reactive Protein and Cardiovascular Risk Factors  
There is limited contemporary information on the distribution of CRP and 
the factors associated with levels of CRP in men and women. Limited data is 
available on the characteristics of those individuals with elevated CRP. Further 
studies are necessary to identify the predictors of elevated levels of CRP.189 It is 
imperative to further understand the interrelationship between CVD risk factors 
and how to reduce the risk of CV events.   
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There are six modifiable risk factors of CVD. Inflammation has been linked 
to all of them. The best prediction of CVD comes from LDL cholesterol levels 
however 50 to 73 percent of CV events occur in the presence of normal LDL 
cholesterol levels.73 Can CRP levels be measured and used in combination with 
other cardiovascular risk factors to better determine risk of heart disease in a 
healthy population? There is still no good marker that exists to independently 
predict the risk of CV events but CRP has been suggested to be used in 
combination with LDL cholesterol levels. 
Researchers in several large scale epidemiological studies have shown 
that CRP is an independent predictor of cardiovascular events however 
relationships between CRP and CVD risk factors have not been fully 
elucidated.190 If CRP is a marker of CVD risk, how does it relate to CVD risk 
factors? In a study by Godefroi et al., CRP was divided into tertiles (less than 1 
mg, 1 - 2.9 mg, and 3 mg or greater). It was observed those with elevated CRP 
were slightly older, more likely female, tending to be obese, less active and have 
been previously diagnosed with either high cholesterol or hypertension.189  
In studies in which regression analyses were used, investigators found 
that measures of obesity were most often related to CRP levels. Ryu et al.191 
related CRP to risk factors of heart disease in subjects greater than 50 years old 
and Raitakari et al. observed that waist circumference, smoking and HDL 
cholesterol accounted for 21.9% of the variance in CRP levels in participants 
aged 21 to 39 years old.192 Kondo et al. examined CRP in middle aged healthy 
Japanese workers and found body fat, BMI and HDL cholesterol to be correlated 
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with CRP (r = 0.6, r = 0.43, and r = -0.63 respectively).193  Saito et al. evaluated 
the relationships between CRP and CVD risk factors in 566 Japanese men and 
women enrolled in a health check program. Univariate regression analysis 
revealed a statistically significant relationship between CRP and BMI (r = 0.28), 
smoking (r = 0.23), and HDL cholesterol (r = -0.22).190 
Recent intervention studies looked at the effects of weight loss or a 
physical activity program on CRP levels. In general, endurance training induces 
changes in CRP that seem to be related to weight loss.194 Post-menopausal 
women,195 obese children, and middle aged women196 had significantly 
decreased CRP levels after completing an exercise program. In a 12 week 
aerobic training study of obese girls by Nassis et al., improvements in insulin 
sensitivity occurred without significant changes in CRP or weight loss.197 Not all 
investigators agree with these findings. Okita et al. did not observe changes in 
CRP and weight, however decreases in CRP were not proportional to amount of 
weight loss.196 
As physical activity (measured by either PA or physical fitness) increases 
the level and amount of CVD risk factors decrease. Physical activity and CRP 
have been linked primarily in the athlete and in those with previous CV events. 
There is limited information on the amount of PA or fitness necessary to control 
levels of CRP. If physical activity does reduce the risk of CVD through 
attenuation of the inflammatory response, what type of relationship exists 
between amount of physical activity and CRP levels? Can CRP be used as an 
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overall indicator of cardiovascular health? How does the relationship between 
CRP and the CV risk factors change when activity level is changed?  
Several recent studies illustrate that CRP levels correspond to levels of 
fitness122, 198 and self-reported physical activity.199, 200 Borodulin examined a 
cross-section of Finns between 25 and 74 years old separating males and 
females into four levels of self-reported conditioning and non-conditioning 
physical activity. It was determined that in women, the highest and lowest 
quartiles of conditioning differed in CRP levels by 27%. Pitsavos et al. looked at 
four levels of self reported activity in Greeks over 18 years old finding the two 
most active groups to have CRP values significantly less than the sedentary 
group.200  
When looking at specific at risk CVD populations, exercise training 
reduced CRP levels significantly more than in the control populations.195, 201 
Goldhammer observed 28 patients with CHD who participated in a 12 week 
aerobic exercise program and found that those with diabetes mellitus, decreased 
CRP levels by 47% and those without DM lowered CRP by 19%.201 Those with 
CHD or high risk of CHD and children who are obese, had greater reductions of 
CRP levels than controls.194, 195, 201  
Summary 
It is still unclear how much physical activity is necessary to avoid the risk 
factors of CVD. Is there a minimal threshold of accumulated activity at which risk 
factors significantly decrease? How much exercise is cardioprotective? The 
Nurses Health study and the Hawaiian Heart Study in measuring physical activity 
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have determined that those with additional energy expenditures of 2000 
kilocalories per week had fewer risk factors than the control subjects. This 
physical activity was gained primarily through brisk walking 2.5 to 3 hours per 
week or 1.5 miles per day. Even walking 1 hour per week lowered relative risk to 
0.80.183  
These energy expenditures were estimated using prediction equations 
based on a healthy able-bodied population and during planned periods of 
exercise. Can similar changes be induced in people who are physically disabled? 
Is there an accurate method of quantifying activity not just during planned 
exercise bouts but during free living?  
The measurement of physical activity during free-living is difficult and 
researchers continue to be plagued by imprecision of measurement techniques 
available that avoid disruption of routine activities.124 Both physical fitness and 
physical activity measurements can be used to define the health benefits of 
exercise, but is there a better measurement available than VO2max or leisure 
time physical activity that helps enhance the quantification of total energy 
expenditure and/or physical activity?202 Is there a measure that better estimates 
physical activity in relation to cardiovascular risk and markers of inflammation?  
Uncertainty remains about the optimal patterns, duration and intensity of 
physical activity necessary to minimize risk of CVD. When observing the 
relationship between physical fitness and CVD, measurements of VO2max or 
estimates of VO2max have been used. The assessment of VO2max requires 
exercise to a maximal volitional exertion level and a high level of motivation by 
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the subject.148 This measure is potentially dangerous often requiring an 
automated external defibrillator and the presence of medical personnel. 
Additionally, it is generally not well tolerated by sedentary individuals, those with 
health problems and those at risk for cardiovascular disease.148 A method that 
quantifies the capacity of an individual to exercise for longer periods of time is 
more appropriate for the general population because people spend the majority 
of their time in submaximal levels of activity.147 Currently there exists limited 
information on ventilatory threshold and the risk factors of CVD.203 To date there 
are no articles published on the relationship of ventilatory threshold to CRP and 
CVD risk. 
The question still remains as to the optimal intensity level necessary for 
reduction of CVD risk. Measures of fitness can provide information on average 
levels of activity but is the relationship of physical activity and CVD related more 
to intensity of activity? Do periods of maximal activity have to be performed on a 
regular basis or can moderate levels of exercise suffice?   
Accelerometry assists with the measurement of physical activity during 
“free living” with recordings of total activity, intensity and duration of bouts 
available for extended time periods. Not much research exists on the use of 
accelerometry to determine CV risk. Would it be possible to use CRP and 
accelerometry to determine amount and intensity of PA to provide protection from 
CV events?  
Both accelerometers and VT measurements can provide assessment of 
overall activity regardless of method of accumulation. Can these methods be 
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used in combination to better quantify total daily physical activity or energy 
expenditure? Can these measurements be utilized in populations with physical 
disability?  
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CHAPTER 2 
RESEARCH QUESTIONS 
 
Main Question 
How is physical activity related to systemic inflammation and the risk 
factors of CVD? 
Study I: Intervention study of healthy, sedentary adults 
By changing the activity levels of a sample of sedentary individuals, can 
systemic inflammation and the risk factors of CVD be lowered?  
Is one method of promoting walking for health better than another and can 
physical activity be increased in the sedentary? 
Study II: Observation of a population cross section of healthy adults  
What is the relationship of systemic inflammation and the CVD risk factors 
to physical activity as measured by activity counts in a cross section of the 
population?  
Study III: Special Populations - survivors of stroke  
How does a sample of the population three months or more after stroke 
compare to age and gender matched sedentary controls in the risk factors of 
heart disease? 
How do daily activity levels of the above populations differ?  
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CHAPTER 3 
INCREASING PHYSICAL ACTIVITY AND REDUCING CARDIOVASCULAR 
RISK USING METHODS OF ACCUMULATING PHYSICAL ACTIVITY 
 
Abstract 
Purposes: To determine effects of two activity accumulation methods on 
increasing physical activity. To determine the effect of resultant physical activity 
increases on expression of CVD risk factors and inflammation. Methods: 
Fourteen volunteers ages 31-66 participated in a 10-week intervention. 
Participants were assigned to group by availability. Groups were randomized to 
10,000 steps or Active Living, Everyday.® Pre/post-intervention testing included 
BMI, waist girth, blood pressure, C-reactive protein (CRP), fitness, cholesterol, 
and blood glucose. Results: Both activity accumulation groups significantly 
increased number of steps (p < 0.05) during the intervention period. No between 
group differences were found in step count, CRP or CVD risk factors. Within 
groups, significant changes in number of steps (95% CI: 4,126 to 1,179 steps per 
day), estimated VO2max (95% CI: 5.22 to 1.18 ml/kg/min), waist circumference 
(95% CI: 6.71 to 0.60 cm) and hemoglobin A1c (95% CI: -0.01 to -0.09 percent) 
were observed. No significant changes were noted in CRP, blood pressure or 
cholesterol. Conclusions: Both programs were equally effective in increasing 
physical activity over 10 weeks. Increases in physical activity resulted in 
improved fitness and blood glucose but were not sufficient to provide changes in 
multiple heart disease risk factors or inflammation.   
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Introduction 
Cardiovascular disease (CVD) is the number one cause of death in the 
United States and its incidence continues to rise.2, 204 Inflammation is related to 
CVD and inflammatory markers have been suggested as indicators of 
cardiovascular events such as stroke or heart attack.80 Physical inactivity has 
been determined to be one of the primary risk factors for cardiovascular disease. 
It is well known that there is an inverse relationship between physical activity and 
cardiovascular disease. Routine physical activity decreases CVD4, 45 and its risk 
factors5-9 and improves health.2   
From the 1996 Surgeon General’s report it was estimated that in the 
United States, more than 60% of adults are not regularly physically active and 
25% are not active at all.2 Current physical activity recommendations from the 
Centers for Disease Control (CDC) and the American College of Sports Medicine 
(ACSM) are to accumulate 30 minutes of moderate level activity most if not all 
days of the week with moderate level activity defined as the equivalent of a brisk 
walk.56 Although it is clear that increased physical activity is associated with 
improved health, the debate continues about the specifics of optimal physical 
activity recommendations.205 
There are many methods for an individual to increase their physical 
activity from participation in competitive sports to a basic walking program. 
Planned, structured physical activity (exercise) has been proven effective at 
improving physical activity, fitness and health, unfortunately only small numbers 
of Americans routinely engage in this type of physical activity and dropout rates 
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are high.206 Because scheduling physical activity into a busy day is often difficult, 
there is a need for alternatives to structured exercise to increase physical 
activity.207  
Rather than performing one 30 minute bout of continuous structured 
physical activity, an alternative method of attaining the CDC/ACSM guidelines is 
through the accumulation of physical activity. It has been suggested that the 
accumulation of physical activity in multiple shorter bouts can provide 
comparable increases in fitness as one continuous bout of similar total 
duration.208   
There are also programs that may allow the accumulation of physical 
activity without any structured bouts of exercise. By incorporating physical activity 
into one’s normal daily activities, one may eliminate the need for scheduling 
physical activity sessions to achieve activity goals. This approach may increase 
program participation and lower dropout rates. Active Living Everyday® (ALED) 
and 10,000 steps are two examples of programs that encourage activity 
accumulation. In these programs, physical activity accumulation is promoted 
primarily through walking activities. Walking is a viable option for most individuals 
and can be performed at minimal to no cost.  
Several studies have examined the 10,000 steps per day target as a 
method of meeting the current national physical activity guidelines.209-212  Other 
studies have investigated the effect of lifestyle behavior change interventions 
similar to ALED on increasing activity.213-215 Participants who exceed 10,000 
steps are more likely to meet the current physical activity guidelines,216 but more 
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research is necessary to examine the effectiveness of these programs on 
increasing physical activity. 
There have been many studies that have examined the relationship 
between individual CVD risk factors and physical activity however, most have 
used physical activity questionnaires to gauge physical activity accumulation. 
Physical activity questionnaires are subjective and can have errors up to 50 
percent.10, 11 The pedometer is a low cost, unobtrusive and easy to use 
alternative to the questionnaire that provides objective monitoring of daily activity 
levels.132, 134 Some health promotion programs, such as 10,000 steps and ALED, 
encourage the use of pedometers to provide both feedback and goal-oriented 
motivation to increase physical activity. There have been some studies on the 
associations of pedometer-measured physical activity with some of  the 
established CVD risk factors,205, 206, 217-220 however, there are few studies on the 
relationship between accumulated physical activity and multiple modifiable CVD 
risk factors.206, 218  
Furthermore, although inflammatory markers such as C-reactive protein 
have been examined in epidemiological studies and in studies of athletes,112, 116-
118 no studies are known to these authors that have examined the effects of 
accumulated moderate level physical activity on C-reactive protein levels. It is 
unclear if the intensity and duration of physical activity recommended in these 
programs is sufficient to lower markers of systemic inflammation and the risk 
factors of heart disease. If activity accumulation programs do result in increased 
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activity levels, how is this increase in physical activity related to measures of 
CVD risk? 
The purpose of this study was twofold. 1. To determine the effects of two 
methods of activity accumulation on increasing physical activity levels in those 
not currently meeting physical activity guidelines. 2. To determine the effect of 
the resultant increase in physical activity on the expression of CVD risk factors 
and inflammatory markers. We hypothesize that both intervention methods will 
be equally as effective in initiation of physical activity and that the resultant 
increase in physical activity will have an effect on some, but not all, of the CVD 
risk factors. 
Methods 
Informed written consent was obtained from all participants. All 
procedures were approved by The University of Montana Institutional Review 
Board for Use of Human Participants and conformed to the Declaration of 
Helsinki. Eighteen subjects were initially recruited. Fourteen volunteers, 2 males 
and 12 females, ages 31 - 66 completed the study.  
The sample of convenience was obtained through flyers posted on a 
university campus and through the employee well-check flyer. All participants 
were tested on the same day and fasted for 12 hours before scheduled testing 
time. As participants arrived, they were asked to complete a consent form and a 
medical history questionnaire as well as a PAR-Q 221 to determine if participation 
criteria were met. The criterion for physical activity was not meeting the daily 
recommendation of 30 minutes of moderate activity. Exclusion criteria included 
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individuals taking medications that would influence heart rate, blood pressure, 
blood glucose or cholesterol, recent infection or surgery within the previous 3 
months, previous heart disease or myocardial infarction.  
Using standard techniques, resting blood pressure was taken in the 
seated position with a mercury sphygmomanometer.222 Waist girth,223 resting 
heart rate, weight and height were also measured. Blood samples were collected 
in the morning after fasting for at least 12 hours before scheduled testing time. 
Two 12 ml vials of venous blood were analyzed at a hospital laboratory for total 
cholesterol (TC), low density lipoprotein cholesterol (LDL), high density 
lipoprotein cholesterol (HDL), blood glucose (HbA1c) and the inflammatory 
marker C-reactive protein (hs-CRP). Samples were analyzed for HbA1c, hs-CRP 
and lipids enzymatically using an automated clinical chemistry analyzer (Roche-
Hitachi P-module, Indianapolis, IN) with estimation calculation of LDL cholesterol 
using the Friedewald equation.79  
Fitness level was measured by the Reebok 1-mile walk test.223 The 
participants were instructed to walk one mile as fast as possible around a pre-
measured 1/3 mile oval track. The elapsed time for the test was recorded and 
heart rate was measured immediately after completing the 1 mile walk. Estimated 
VO2max was calculated using the Reebok walk test prediction equation.223 
At the completion of the testing, participants were issued a digital 
pedometer (Walk for Life, Plainfield, IL) and instructed to wear it on the 
waistband of their clothes every day whenever out of bed except when bathing. 
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Participants wore the pedometer for 5 to 7 days prior to the first intervention 
meeting to determine baseline physical activity.  
Although intervention type was randomly assigned to the 2 groups, 
participants were placed into groups of convenience according to group meeting 
time. Equal numbers of males and females were assigned to each group. Group 
1 participated in an educational lifestyle behavior change program, ALED,224 in 
which physical activity was encouraged throughout the day. Group 2, 10,000 
steps, was a goal-oriented walking group encouraged to attain 10,000 steps 
daily. Both groups met weekly for one hour to standardize contact time.  
Intervention  
The intervention phase consisted of each group meeting one hour per 
week for a total of 10 weeks. All participants were asked not to change their 
dietary behaviors during the study period. Each week, attendance was taken and 
the investigators recorded the pedometer data for each participant in both 
groups.  
During these meetings, group 1 attended an ALED class promoting 
lifestyle behavioral change. Active Living Everyday®  is an educational program 
that uses social cognitive theory and the transtheoretical model (stages of 
change) to encourage behavior change towards an active lifestyle.225  This class 
is offered through Human Kinetics (Champaign, IL) and each of the participants 
in the group received a workbook and a log to record daily physical activity.224 
This program encourages an increase in walking whenever possible throughout 
the day to accumulate a total of at least 30 minutes of moderate intensity activity. 
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Each module provides education on topics related to increasing activity and 
readiness for change is assessed periodically throughout the program. See table 
1 for examples of topics covered in the ALED course. A group facilitator trained 
by Human Kinetics worked with participants following the modules in the 
workbook. These interactive lessons encourage problem solving to introduce 
techniques and strategies that can be individualized to assist in achieving a more 
active lifestyle.  Some modules were accelerated or combined to tailor the 
program to the group and because some of the topics such as pedometer use, 
the one-mile walk and self-monitoring of heart rate were covered during the pre-
test session. No structured exercise was performed during these group meetings 
although physical activity was occasionally incorporated to emphasize major 
points such as learning how to perform a walking test. 
Group 2 followed the traditional 10,000 steps walking program. The 
10,000 steps program is a widely advocated method of increasing physical 
activity originally created by Yoshiro Hatano (1993) in Japan.209  The goal of this 
program is to gradually increase the total number of steps taken in one day to 
10,000 and to maintain or exceed this level of accumulating 10,000 steps 
everyday. The only instructions to participants were to increase their walking 
opportunities whenever possible throughout the day and to gradually increase 
number of steps until 10,000 steps was reached or exceeded. This group 
participated in a weekly meeting lasting one hour. During this meeting, 
attendance was taken, pedometer readings were recorded and a group walking 
session was offered. No formal instruction occurred during these sessions. The  
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Table 1 
Topics Covered in the Active Living, Everyday® Program 
Increasing activity Goal setting 
Intensity and 
duration 
Stress 
Previous success 
Time 
management 
Balancing 
calories 
Using 
pedometers 
Benefits of 
activity 
Positive changes 
Measuring heart 
rate 
Avoiding pitfalls 
Barriers 
Stretching 
exercises 
Walking test Problem solving 
New activities Lasting changes 
Support 
enlistment 
Self reward 
 
Table 1: Topics covered in the educational program that uses social cognitive 
theory and the transtheoretical model to encourage changes in behavior and an 
active lifestyle. 
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Table 2   
 Baseline Descriptive Data 
 ALED 10,000 steps 
Age (yrs) 45.71 + 8.65 51.29 + 7.74 
Height (m) 65.14 + 2.13 66.25 + 3.76 
Weight (kg) 76.10 + 17.88 79.89 + 8.95 
Daily Step Count 6,788 + 2,492 6,591 + 1,884 
BMI (kg/m2) 27.54 + 5.34 28.22 + 3.81 
Waist girth (cm) 82.86 + 13.87 84.31 + 9.95 
SBP (mmHg) 111.14 + 18.07 114.67 + 12.37 
DBP (mmHg) 76.00 + 8.08 78.50 + 9.46 
 
Baseline descriptive data for accumulated activity groups Active Living, 
Everyday® and 10,000 steps groups. Yrs = years, m= meters, kg = kilograms. 
BMI = body mass index, cm = centimeters, SBP = systolic blood pressure,  
mmHg = millimeters of mercury, DBP = diastolic blood pressure  
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primary purpose of this meeting was to record pedometer readings and to 
standardize contact time with participants between the 2 groups. After ten group 
sessions were completed, all participants were retested in the same manner as 
the pretesting.  
Data Analysis  
T-tests were performed to analyze differences between groups in age and 
attendance. Repeated measures analysis of variance was used to assess 
differences over time between the ALED and 10,000 steps intervention groups 
for the following dependent variables: cholesterol (TC, HDL, LDL), HbA1c, blood 
pressure, CRP, BMI, waist girth, steps per day, and estimated VO2max. 
Significance levels were set at p < 0.05. 
Results 
Initial enrollment in the study was 18 however one participant underwent 
shoulder surgery, two were unable to attend the post testing and one withdrew 
due to personal issues. Two males and 12 females, 1 male and 6 females in 
each group, completed the 10-week intervention. Descriptive variables are listed 
in table 2. There were no significant differences between the groups. Average 
age of subjects was 48.5 + 9.2 years. Baseline step counts were 6,591 + 1,884 
steps for the 10,000 steps group and 6,788 + 2,492 steps for the ALED group.  
Average weekly step counts for each group are depicted in figure 2. Both groups 
significantly increased their step count with 10,000 steps increasing to as high as 
10,334 + 2,037 steps per day and ALED increasing to as high as 9,943 + 2,308 
steps per day during the intervention period. The mean step count at the end of  
Figure 2 
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Figure 2: Changes in the average number of steps per day by group as 
measured by pedometer over the ten week intervention period. ALED = Active 
Living, Everyday.® 
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the 10 weeks was 9,892 + 3,690 for 10,000 steps and 9,056 + 2,348  for the 
ALED group. Weekly meeting attendance was significantly less in the walking 
group than the ALED group (p < 0.05 level) with attendance averaging 54.3% for 
10,000 steps and 72.5% for ALED. There were no differences between groups 
found for any of the dependent variables of interest (step count, CVD risk factors 
or CRP). Because none of these dependent variables significantly differed 
between the ALED and 10,000 steps treatment groups, the results for all 
participants were combined and analyzed together as one group. 
Results for all subjects are listed in table 3. There were significant 
changes in number of steps (95% confidence interval: 4,126 to 1,179 steps per 
day). Significant changes were also observed in estimated VO2max (95% 
confidence interval: 5.22 to 1.18 ml/kg/min), waist circumference (95% 
confidence interval: 6.71 to 0.60 cm) and hemoglobin A1c (95% confidence 
interval: -0.01 to -0.09 percent). Physical activity increased by 2,704 steps or 
43%, from a baseline of 6,690 + 2,125 to an average of 9,542 + 2,922 steps per 
day. By the end of the 10 weeks, 4 participants (29%) exceeded 10,000 steps 
and 83% of participants increased physical activity levels. Increases in VO2max 
were 3.2 ml/kg/min or 11% and decreases in HbA1c was from 5.19 to 5.14 or 1% 
over the 10 week period. There were no significant changes in BMI, CRP, blood 
pressure or cholesterol levels.  
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Table 3 
 
Results: All Subjects 
 Baseline  10 weeks 
Daily Step Count 6,690.00 + 2,125 9,541.99 + 2,922* 
BMI (kg/m2) 28.58 + 4.97 28.42 + 4.57 
Waist girth (cm) 85.17 + 13.29 88.82 + 10.66* 
SBP (mmHg) 116.29 + 19.64 117.14 + 16.78 
DBP (mmHg) 77.36 + 8.167 77.57 + 9.52 
est VO2max (ml/kg/min) 29.00 + 9.61 32.20 + 10.01* 
HbA1c (%) 5.19 + 0.15 5.14 + 0.15* 
Total Cholesterol (mg/dl) 206.50 + 33.80 205.21 + 36.59 
Triglycerides (mg/dl) 144.50 + 108.20 137.43 + 76.21 
HDL (mg/dl) 61.71 + 16.14 62.71 + 14.90 
LDL  (mg/dl) 118.29 + 29.12 115.00 + 28.40 
CRP (mg/dl) 0.21+ 0.18 0.20 + 0.15 
 
Table 3: Dependent variable results of pre- and post-testing for all subjects. * 
indicates statistically significant differences at p = 0.05. BMI = body mass index, 
kg = kilograms m2 = meters squared. cm = centimeters, SBP = systolic blood 
pressure, DBP = diastolic blood pressure, mmHg = millimeters of mercury, est 
VO2max = estimated maximum volume of oxygen consumed, HbA1c = 
glycosylated hemoglobin, mg = milligrams, dl = deciliter, HDL = high density 
lipoprotein cholesterol, LDL = low density lipoprotein cholesterol, CRP = C-
reactive protein. 
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Discussion 
 Because of the low adherence levels to structured exercise programs,207 it 
is important to find alternate means of increasing physical activity in the general 
population. When activity can be incorporated into daily routine, it becomes more  
appealing and less intimidating.226 Adherence to activity programs has improved 
when activity accumulation methods have been utilized.227, 228  
Both the ALED and 10,000 steps programs promote the integration of activity into 
daily living and in this study resulted in similar outcomes after 10 weeks of 
intervention. Our results support the findings of previous research. Both the 
ALED and 10,000 steps groups were effective in increasing physical activity, as 
measured by average daily step count, with neither method more effective than 
the other.  
By incorporating a gradual, moderate approach to increasing physical 
activity into daily routine, daily energy expenditure215 and fitness227, 228 have been 
increased. In the current study, attained increases in physical activity, as 
measured by step count, resulted in increased physical fitness as measured by 
estimated VO2max. In addition, 29% of our subjects, two from each group, 
exceeded 10,000 steps by the end of the 10 weeks. These results are similar to 
previous research. In a study of Japanese workers, 42% of participants 
exceeded the 10,000 steps for 4 weeks but only 11% exceeded for 12 weeks.219 
When the participants were grouped together in the current study, 
baseline step counts were 6,690 + 2,125. In a study of people with type 2 
diabetes mellitus by Ariaza et al., baseline data was similar to the current study 
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with the control group baseline at 6,239 ± 2,985 and the active group baseline at 
7,220 ± 2,792 steps per day. Baseline counts in other pedometer studies ranged 
from a low of 4,491 up to a high of 5,753 steps per day.205, 206, 217, 219 With the 
exception of the Ariaza study, other activity accumulation studies began with 
participants who were less active than those in the current study.218  
Resultant physical activity after 10 weeks was similar to 2 other participant 
groups. The final step count of 9,542 steps attained in the current study were 
comparable to the steps attained in a 12 week study by Tudor-Locke et al.217 of 
9,123 steps and in an 8 week study by Swartz et al.206 of 9,213 steps. Changes 
in activity in these studies were 3,737 steps or 37% and 4,722 steps or 51% 
respectively.  Physical activity increased by 43% in the current study. Other 
studies using 10,000 steps as a goal resulted in higher daily step counts. 
Hultquist et al. recorded step counts of 10,410 and Ariaza et al. observed 
increases to 10,159 steps. Hultquist et al. recorded an increase of 4,807 or 46% 
in a 4 week observation,205 and Ariaza et al. observed an increase of 2,939 steps 
or 29% in 6 weeks.218 The studies by Swartz et al. and Hulquist et al. resulted in 
the greatest increases in physical activity. 
In the current study, significant changes in CVD risk factors were 
observed in glycosylated hemoglobin as measured by HbA1c and fitness level as 
measured by estimated VO2max.  No significant changes in blood cholesterol 
levels or blood pressure were observed. A reduction in average blood glucose 
levels occurred in the current study by increasing step counts by as little as 2,704 
steps per day over 10 weeks. However, significant decreases in other CVD risk 
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factors such as blood pressure or cholesterol did not occur (see table 3). Other 
studies that have assessed the effect of the 10,000 steps program on CVD risk 
factors have had both similar and conflicting results.205, 206, 219  
In studies of activity accumulation, the most commonly utilized blood 
glucose measurements have been fasting blood glucose and HbA1c. Glucose 
tolerance tests also provide valuable information on impaired glucose 
metabolism. Levels of HbA1c dropped 1%, from 5.19 to 5.14 in our study. This is 
a clinically significant change and comparable to other intervention studies of 
sedentary participants where education on physical activity was provided and 
activity increases were voluntary. In these studies, levels of HbA1c decreased by 
0.8, and 0.6%.229-231 When examining other studies that used the 10,000 steps 
intervention, no change in HbA1c was observed after interventions of 6 and 12 
weeks in length.218, 219 In a 10,000 steps study, Swartz et al. monitored blood 
sugar levels with fasting blood glucose and 2-hour glucose tolerance rather than 
HbA1c. In this 8 week study of people with type 2 diabetes, statistically significant 
improvements were found in 2-hour glucose tolerance but not in fasting blood 
glucose.206 Other activity accumulation studies did not assess blood glucose.205, 
225 The 1% decrease in average blood glucose levels we observed is a positive 
change towards lowering CVD risk. 
In the current study, increases in VO2max and waist circumference were 
observed however no significant changes were found in BMI. Increases in 
VO2max were 3.2 ml/kg/min in the current study. This finding is consistent with a 
meta-analysis of walking interventions in which significant increases in VO2max 
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of 3.6 + 0.5 ml/kg/min were obtained without statistically significant changes 
occurring in either BMI or percent body fat.232 Our findings are in agreement with 
previous studies using activity accumulation where despite improvements in 
physical activity and/or fitness, no improvements in obesity measures were 
observed.205, 206, 218, 219 
Accumulation of activity over time may be sufficient to produce changes in 
fitness but not decreases in BMI or other CVD risk factors. As in our study, no 
improvements in LDL cholesterol or HDL cholesterol, BMI or weight were seen in 
the previously mentioned activity accumulation studies. As stated in our 
hypothesis, we did not expect changes in all of the CVD risk factors. To obtain 
greater improvements in CVD risk factors, higher intensity activity may be 
necessary than that needed for improvement in fitness.223  Higher intensity 
aerobic dance, compared with low-intensity walking was more effective in 
improving CVD risk factors.233 In general, stronger associations of CVD risk 
factors have been found with higher intensity activities.234   
One of the factors that may result in the greatest changes in CVD risk 
factors is weight loss because obesity is linked to many of the CVD risk 
factors.235 Even modest weight loss has resulted in decreased fat mass, blood 
pressure, blood glucose, low-density lipoprotein, and triglyceride levels.236 
Weight loss can be achieved by increasing physical activity or decreasing dietary 
intake. Improving both physical activity and diet may provide the greatest weight 
loss. Despite the benefit of changing both diet and physical activity, we wanted to 
focus on the effects of physical activity on CVD risk factors. Therefore, we 
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controlled for dietary influences by asking participants to maintain their dietary 
habits. The activity accumulation programs used in the current study did not 
result in weight loss. It is likely that either dietary changes or a greater physical 
activity intensity level is necessary for weight decreases to occur. 
The effects of activity accumulation on changes in blood pressure have 
also been varied. Our study is consistent with 2 other studies in that blood 
pressures did not significantly change from initial measurements.218, 219 The 
mean systolic blood pressure in our study was 116.3 + 19.6 mmHg and the mean 
diastolic blood pressure was 77.4 + 8.2 mmHg.  Two other studies using 10,000 
steps interventions, Hulquist et al. and Swartz et al., observed significant 
decreases in blood pressure.205, 206  Changes in physical activity (as measured 
by change in step counts of 4,722 and 4,807 steps) were greater in these 2 
studies than the other activity accumulation studies. In comparison, the increase 
in step count in the current study was 2,704 and in the Ariaza et al. study was 
2,939 steps. It may be that greater changes in physical activity may be necessary 
to affect changes in blood pressure.  
The systemic inflammatory marker C-reactive protein (CRP) has been 
suggested as an indicator of CVD risk. In general, there appears to be an inverse 
relationship between physical activity and CRP levels.47, 104, 107 However, CRP 
has not yet been established as a predictor of CVD events in the general 
population. Some researchers have noted decreases in levels of CRP in athletes 
with regular training48, 99 but the results have not been consistent across 
sports.108, 120 We did not observe any significant changes in CRP levels after the 
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10-week intervention in our sample of the population. The baseline values we 
observed were similar to that of other research,48, 99, 108, 120 however, we 
observed a high variation within and among participants. Within subject variation 
of CRP is 4 to 6 x greater than that of cholesterol.100 Baseline levels of CRP are 
known to fluctuate up to 60% and this variation of CRP makes it difficult to use in 
all but epidemiological studies with large numbers.100  
Accumulated physical activity can provide increases in fitness and 
physical activity. Programs such as 10,000 steps and ALED provide alternatives 
that are less intimidating to those who have not previously exercised. This 
approach to physical activity may allow for improvement in success rates and 
decreases in drop-out rates that are so apparent in structured activity programs. 
Because physical activity can be incorporated into a busy day, accumulation 
programs may increase adherence and provide opportunities for successfully 
increasing physical activity. The focus of these activity accumulation programs is 
to increase opportunities for physical activity and provide a vehicle for 
participants to increase total activity. This is an important step, to promote 
lifestyle changes and begin the journey towards being physically active. 
However, it may be necessary to provide additional guidance on activity 
parameters, particularly intensity.  
Positive changes in some CVD risk factors occurred with accumulated 
walking programs after 10 weeks in the current study and after 4 – 12 weeks in 
other similar studies.205, 206, 219 Effecting decreases in other CVD risk factors may 
require a minimal intensity or higher activity accumulation. Researchers suggest 
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that the total amount of moderate level physical activity accumulated, regardless 
of  accumulation method, is important for health benefits.237 Participants who 
accumulated 10,000 steps per day were more likely to meet the current physical 
activity guidelines but accumulation of 10,000 steps did not guarantee 
success.216 The challenge of using activity accumulation programs to increase 
physical activity is that activity intensity is generally not emphasized. Hatano 
(1993) stressed the importance of walking intensity at a “fairly fast pace” in his 
10,000 steps program.209 However, emphasis on intensity of physical activity has 
been lost in the public promotion of this program within the United States. 
Intensity is an important component for reduction of CVD risk. To more effectively 
reduce multiple CVD risk factors, accumulated activity programs may need to 
incorporate a focus on incremental increases in activity intensity as well as 
activity accumulation. 
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CHAPTER 4 
EXPLORING THE RELATIONSHIP BETWEEN CARDIOVASCULAR DISEASE 
RISK AND PHYSICAL ACTIVITY AS MEASURED BY ACCELEROMETERS 
 
Abstract 
Purpose: The purpose of this study was to explore the inverse relationship 
between global CV risk scores and PA. A secondary purpose was to determine 
the PA intensity and duration best associated with reduced CV risk.  
Cardiovascular disease (CVD) accounts for 37.1 percent of all deaths in the 
United States.238 Many of these deaths are preventable with reduction in 
sedentary behaviors. Using individual independent risk factors for CVD, global 
CV risk scores like the Framingham have been developed to predict individual 
CVD risk. Although sedentary lifestyle has been identified as 1 of the 8 known 
risk factors for CVD, no known global risk scores include measures of physical 
inactivity. The exclusion of physical inactivity in CV risk scores is attributed to the 
difficulty in reliably quantifying physical activity (PA) levels of individuals. There is 
a need to better quantify habitual PA and to include PA in global risk 
assessment. Methods: Forty five males and 65 females completed this study. 
Weight, height, resting blood pressure, waist girth and skinfold measurements 
were taken. Body mass index (BMI) was calculated. An accelerometer was worn 
on the right hip for 7 full days including a weekend period. A blood sample was 
analyzed for total cholesterol (TC), low density lipoprotein cholesterol (LDL), high 
density lipoprotein cholesterol (HDL), triglycerides, and glycosylated hemoglobin 
 76
(HbA1c). Based on established values for each gender, absolute risk ranks were 
developed for systolic and diastolic blood pressure, total cholesterol, HDL 
cholesterol and LDL cholesterol, percent body fat and waist girth, and 
glycosylated hemoglobin (HbA1c). To obtain global CV risk ranks, absolute risk 
ranks were summated for each individual. Habitual PA was examined using 
multiple methods. Activity was divided into sedentary, light, moderate and 
vigorous levels to examine intensity. To consider duration, time spent in each 
category was examined. To further explore intensity, individual minutes of 
highest intensity achieved for each day were examined for durations of 5 minutes 
(hct5) up to 120 minutes (hct120) in 5 to 15 minute increments. Total activity and 
average counts per minute per day were also determined. T-tests analyses were 
used to determine differences between genders and one-way ANOVAs were 
used to evaluate age group differences for minutes of activity at various intensity 
levels. Pearson correlations between CV risk scores and PA patterns were 
calculated. The 2 PA methods with highest correlations to CV risk scores were 
then used in a multiple regression analysis with age and by gender to develop 
prediction scores for CV risk. Statistical significance was set at p < 0.05. Results: 
Of the participants in our study, 67% met or exceeded the recommended minimal 
PA guidelines of 30 minutes of moderate PA 5 of 7 days per week and 45% met 
these guidelines 6 of 7 days per week. Overall, participants spent 73% of time in 
sedentary activities, 19.6% in light activity, 5.5% in moderate activity and 1.8% in 
vigorous activity. The best fit regression line of CV risk score for men was with 
total daily activity and age (r = - 0.53, standard error of the estimate (SEE) = 
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0.58). For women, hct30 and age had the best fit (r = -0.44, SEE = 0.50). When 
analyzed by age group, the best fit line for group 1 (ages 18-24) was with hct5, r 
= -0.45, SEE = 0.40 and the best fit line for group 2 (ages 25-44) was with total 
counts, r = - 0.41 and the SEE = 0.71. No significant regression line was found 
for Group 3 (ages 45-65) but total counts provided the best fit line at r = -0.33, 
SEE =0.53, p = 0.06. Conclusion: Total daily activity and total time in moderate 
activity were inversely related to CVD risk. However, reaching higher intensity 
levels for 1 minute periods accumulated for at least 5 minutes a day appears to 
be better related to lower risk of CVD than longer durations of moderate or 
vigorous activity per day, particularly at younger ages.   
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Introduction 
Physical activity (PA) has long been associated with health benefits.2 As 
early as 1979, the Framingham study identified physical inactivity to be related to 
cardiovascular disease (CVD) mortality and morbidity.239  In 1992, physical 
inactivity was recognized as a fourth major risk factor for coronary heart disease 
by the American Heart Association.240  There are currently a total of 8 risk factors 
for CVD. They include age, family history, smoking, hypertension, dyslipidemia, 
physical inactivity, diabetes and obesity.2 From these individual independent risk 
factors, equations have been developed to determine overall or global CV risk 
scores (eg. Framingham, Modified Sheffield, New Zealand, Joint British 
Recommendations). The Framingham risk equation is the “gold standard” and 
includes gender, total cholesterol, high density lipoprotein cholesterol (HDL), 
blood pressure, age, and smoking in the calculations.241 The original 
Framingham equation also included left ventricular hypertrophy.242  Other risk 
estimates such as the modified Sheffield, the Joint British and New Zealand add 
diabetes to improve on sensitivity and specificity. Unfortunately, none of these 
global risk equations include physical inactivity. The exclusion of physical 
inactivity in CV risk scores is attributed to the difficulty in reliably quantifying PA 
levels of individuals. 
Habitual PA has been difficult to measure without high cost or imposition 
upon free living. The two standards for PA measurement that have been most 
practical for large scale studies have been self-report and cardiorespiratory 
fitness (fitness).124, 243 Discrepancies regarding intensity level are common when 
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using self reported activities, with estimated error ranging from 35 to 50 percent 
depending on individual recall and perception of activities.10, 11 Large cohort 
studies have found fitness, as measured by VO2max, to be inversely related to 
all-cause and CVD mortality.128, 130 However, fitness testing provides information 
about maximal exercise capacity without details regarding habitual activity 
patterns.  There is a need to better quantify habitual PA and to improve our 
understanding of the relationship between PA and CVD.  
Technological advances have allowed for objective measurement of 
habitual PA through the use of accelerometers. Accelerometers are motion 
sensors that provide a description of free-living PA in real time including intensity, 
duration and frequency. These devices can record and store data for extended 
periods of time. There have been several studies using accelerometers 
individually relating the single risk factors of obesity,244-246 cholesterol140 and 
blood pressure247 to habitual PA. The majority of this bivariate research has 
analyzed PA using total activity counts. There exist no studies known to this 
author that relate a global CV risk score to PA.  
The purpose of this study was to explore the inverse relationship between 
global CV risk scores and PA. A secondary purpose was to determine the PA 
intensity and duration best associated with reduced CV risk.  
Methods 
Eligible participants were apparently healthy males and females between 
18 and 65 years old. Individuals taking medications that would influence heart 
rate, blood pressure, blood sugar or cholesterol, with recent infection or surgery 
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within the previous 3 months, or those with previous heart disease or myocardial 
infarction were excluded from the study. Informed written consent was obtained 
from all subjects with all procedures approved by the Institutional Review Board 
at The University of Montana. 
A sample of convenience was obtained primarily through word of mouth 
from the local area population. An attempt was made to obtain a fair 
representation of young (18-24), middle (25-44) and older (45-65) age ranges, 
both male and female genders and both active (fit) and sedentary (unfit) 
individuals. One hundred forty subjects (65 males, 75 females) volunteered for 
this study, completed a fasted blood draw, performed exercise testing and wore 
an accelerometer for a week. Complete data were present for 110 subjects (45 
males, 65 females) who were used for this analysis. 
When participants arrived for their testing session, they were asked to 
complete a consent form, a medical history questionnaire and a PAR-Q221 to 
determine if participation criteria were met. After sitting quietly for 5 minutes, 
resting heart rate was observed and resting blood pressures were taken using 
the procedures recommended by the American Heart Association.222 Weight and 
height were measured and recorded and from these measurements body mass 
index (BMI) was calculated.223 Waist girth and skinfold measurements were 
taken per American College of Sports Medicine (ACSM) recommended 
protocols.223 Using the gender specific three-site protocol, skinfold measures 
were converted into percent body fat using the ACSM recommended Jackson-
Pollock equations.223  
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At the completion of the above testing, participants were fitted with an 
Actical accelerometer (Minimiter, Bend, Oregon). The Actical activity monitors 
are small (2.8 x 2.7 x 1.0 cm3), lightweight (17g) units that have a primary plane 
of detection but are sensitive to all three planes of motion. The Actical is a piezo-
electric accelerometer with a range of 0.5 to 2G and frequency of 0.35 to 3.5 Hz. 
The Actical samples acceleration at a rate of 32 Hz and integrates this over the 
user-defined epoch.248 In this study, the epoch was set at 1 minute, comprising a 
total of 1440 measurements for each day. The accelerometer was worn on the 
right hip for 7 full days including a weekend period. Participants were asked to 
wear it every day whenever out of bed except when bathing. Log sheets were 
provided to record any activities such as motorcycle riding or snowmobiling that 
might overestimate activity and any times where they neglected to wear the 
device.  Previous research has shown that in adults, a minimum of 3 to 5 days of 
monitoring is optimal to determine activity patterns.140, 142 Monitoring for 7 days 
was chosen to ensure inclusion of both weekday and weekend as conflicting 
evidence exists regarding differences between weekday and weekend habitual 
activity patterns.140, 249  Placing a single device on the hip or lower back is 
recommended by Trost et al. in a review of accelerometer studies.142  
A blood sample was collected from the participants within 2 weeks of the 
testing session detailed above. Participants were asked to fast for 12 hours prior 
to blood sample collection. Two 12ml vials of venous blood were drawn and 
analyzed at a hospital laboratory for lipids [total cholesterol (TC), low density 
lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), 
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triglycerides], and glycosylated hemoglobin (HbA1c) to measure average blood 
glucose. Samples were analyzed for HbA1c and lipids enzymatically using an 
automated clinical chemistry analyzer (Roche-Hitachi P-module, Indianapolis, IN) 
with estimation calculation of LDL cholesterol using the Friedewald equation.79  
Data Analysis 
When activity monitors were returned, the data were downloaded into a 
computer data file. Using the activity log sheets completed by the participant, 
data for time periods that might overestimate activity such as snowmobile riding 
or driving a truck on a dirt or bumpy road were eliminated. Also, all Actical files 
were screened for periods of zero activity. If the Actical was not worn, per report 
on the activity log sheet, this data was removed from the analysis. 
Cardiovascular Disease Risk Calculation  
Our primary objective was to investigate whether the clustering of risk 
factors was related to habitual PA in a population sample of adults aged 18-65. 
To compute CV risk ranks, an absolute rank was developed based on 
established values for each gender for systolic and diastolic blood pressure,250 
total cholesterol, HDL cholesterol and LDL cholesterol,251 percent body fat252 and 
waist girth,253, 254 and glycosylated hemoglobin (HbA1c).254 The values used are 
listed in table 4. For risk factors directly related to CVD such as systolic blood 
pressure, ranks were calculated as the recorded value divided by 130, the 
established cutoff value for hypertension. A person with systolic blood pressure 
of 120 would receive a rank of 120/130 or 0.92 while someone at 140 would 
receive a score of 140/130 or 1.08. For risk factors indirectly related to CVD such 
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as HDL, for a male with an HDL score of 50, absolute risk was calculated as 1-
(50/40) or -0.25. 
Once ranks were calculated for all individual risk factors, these ranks were 
summated to obtain an absolute global risk rank for each individual. Several 
different global risk equations were explored based on the measured CV risk 
factors and are listed in table 5. For the purpose of this study, global risk 
equations were selected that incorporated a majority of the modifiable risk 
factors. Smoking was not included in the CV risk score calculations because so 
few smokers volunteered for the study. Absolute risk A was calculated by 
summation of the absolute ranks of 7 factors: average blood glucose (HbA1c), 
systolic and diastolic blood pressure, LDL cholesterol, HDL cholesterol, waist 
girth, and body fat. Absolute risk B substitutes total cholesterol for LDL 
cholesterol and Absolute risk C, a non-obesity CV risk score, omits the waist girth 
and body fat absolute risk scores from the calculations.  
Patterns of Activity 
A purpose of this study was to examine various parameters of PA which 
might be best related to global risk for CVD. To evaluate this question, multiple 
methods of looking at daily PA were produced from the raw accelerometer data. 
Prior accelerometer studies have used total activity counts and duration of 
moderate and vigorous activity to investigate PA patterns.140, 249 Since previous 
studies suggest a minimum of 3-5 days to provide an accurate representation of 
habitual physical activity,140, 142 at least 5 days of accelerometer data were  
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Table 4   
 Established Risk Values By Gender 
   Males  Females 
 Percent Fat 25% 30% 
 Systolic Blood Pressure 130 mmHg 130 mmHg 
 Diastolic Blood Pressure 85 mmHg 85 mmHg 
 LDL 130 mg/dl 130 mg/dl 
 HDL 40 mg/dl 50 mg/dl 
 Total Cholesterol 200 mg/dl 200 mg/dl 
 Waist girth 101.6 cm 88.9 cm 
 HbA1c 7% 7% 
    
  
Table 4: Established values indicating increased risk for each of the measured 
parameters separated by gender. % = percent, mmHg= pressure in millimeters of 
mercury, LDL = Low density lipoprotein, HDL = high density lipoprotein, mg = 
milligrams, dL= deciliter, cm = centimeter. 
Table 5 
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required to qualify for analysis in the current study. In order to examine PA 
parameters, total counts per day (TAC) and average counts per minute per day 
were determined first. Next, to examine intensity, activity was divided into 
sedentary, light, moderate and vigorous. To examine duration, time spent in each 
category was considered. Minute-by-minute PA counts were separated into these 
categories according to their estimated PA energy expenditure expressed in 
metabolic equivalents or METs and were defined from previous research of 
Heil.255 Sedentary was considered activities of less than 1 MET (0-99 cts/min). 
Light activities included activities of 1.1-2.9 METs (100-1500 cts/min). Moderate 
activities required activities of 3-6 METs (1500-6500 cts/min) and activities that 
were greater than 6 METs were considered vigorous (greater than 6500 
cts/min).56   
Once the intensity levels were calculated, multiple methods of viewing 
activity were developed including average non sedentary counts, total counts in 
each category, counts per minute in each category, and duration in single 
minutes per day at various intensity levels. Since the current PA 
recommendations are for accumulation of activity in bouts of 5 minutes or more,2 
analysis included average counts and total time in moderate (Tmod) and 
vigorous (Tvig) activity accumulated in 5 minute bouts or greater. To further 
explore the effect of intensity, the individual minutes of highest intensity achieved 
for each day were located. Then the highest counts per minute achieved for 
durations of 5 minutes (hct5) up to 120 minutes (hct 120) in 5 to 15 minute 
increments were observed. Again, these were the single minutes of highest 
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intensity or the minutes which had the highest number of counts per minute. 
Activity was analyzed as an average for all days and then further analyzed as 
average weekends and weekdays separately because previous research had 
suggested that there may be differences in activity patterns during the week and 
on weekends.140, 249 
Statistics 
Means and standard deviations of descriptive variable and each risk factor 
were calculated within each age group. T-tests analyses were used to determine 
gender differences and one-way ANOVAs were used to evaluate age group 
differences for minutes of activity at various intensity levels. T-tests were also 
performed to examine differences in activity patterns between weekend and 
weekday activity. Variables used for the weekend – weekday analysis were time 
spent in each intensity level (sedentary, light, moderate and vigorous) overall and 
by age group. A p value of less than 0.05 was considered to be statistically 
significant. 
Pearson correlations between the global CV risk scores and PA patterns 
were calculated to determine which CV risk score had the highest correlations to 
PA. The 2 PA methods with highest correlations to CV risk scores were then 
used in a multiple regression analysis with age and by gender to develop 
prediction scores for CV risk. Correlations of PA methods with CV risk were also 
performed by gender for each of the three age categories. SPSS 12.0 (SPSS, 
Inc., Chicago, Illinois) was used for all data analyses. To adjust for multiple 
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comparisons in the correlational analyses, a p value of less than 0.001 was 
considered statistically significant.  
Results 
Forty five males and 65 females had complete data sets and were used in 
the data analysis. Age of subjects ranged from 18 to 64 with mean age of 34.6 + 
13.8 years. The body mass index (BMI) of subjects ranged from 18.2 to 44.2 
kg/m2. Minimum, maximum and means + standard deviations of descriptive 
variables and individual CV risk factors for each age group are displayed in table 
6.   
Of the participants in our study, 67% met or exceeded 30 minutes of 
moderate PA 5 of 7 days per week and 45% met these guidelines 6 of the 7 days 
per week. Sample averages were 73% of time in sedentary activities, 19.6% in 
light activity, 5.5% in moderate activity and 1.8% in vigorous activity. There was 
no statistical difference found between weekdays and weekend days in time 
spent in each intensity category. Time spent in sedentary, light, moderate and 
vigorous activity for weekends, weekdays and all days are displayed in table 7.  
When PA was analyzed by gender (table 8), men and women did not 
significantly differ in amount of sedentary (1061.6 minutes + 90.8 versus 1066.3 
+ 95.9 minutes), light activity (285.2 + 74.1 minutes versus 294.1 + 76.4 
minutes), moderate activity (85.7 minutes + 44.2 men and 70.4 + 41.7 women) 
and vigorous activity (7.5 minutes + 6.6 men and 9.2 minutes + 10.0 women). 
Subjects were also analyzed by age category (table 8). Moderate and vigorous 
activity time was highest in the youngest age group and decreased with  
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Table 6          Descriptive Statistics By Age 
   Mean 
Standard 
Deviation Minimum Maximum
Height (m) Younger 1.70 0.10 1.48 1.91 
  Middle 1.70 0.08 1.57 1.90 
  Older 1.71 0.08 1.58 1.98 
Weight (kg) Younger 67.83 11.51 48.75 95.20 
  Middle 77.90 20.52 54.15 140.30 
  Older 77.78 15.47 45.70 106.80 
Younger 19.23 8.17 5.14 40.21 Percent body 
fat (%) Middle 24.82 9.78 9.44 44.34 
  Older 29.98 7.70 15.10 41.90 
Younger 118.20 7.81 102.00 134.00  Systolic 
BP(mmHg) Middle 123.12 16.16 91.00 168.00 
  Older 122.09 12.49 94.00 150.00 
Younger 73.59 6.55 58.00 88.00 Diastolic BP 
(mmHg) Middle 79.55 11.84 49.00 118.00 
  Older 79.73 10.56 59.00 108.00 
LDL (mg/dl) Younger 88.64 22.57 43.00 154.00 
  Middle 83.48 28.43 20.00 135.00 
  Older 103.52 25.11 44.00 161.00 
HDL (mg/dl) Younger 63.64 17.33 36.00 127.00 
  Middle 62.39 18.06 33.00 95.00 
  Older 67.79 16.93 41.00 111.00 
HbA1c (%) Younger 5.04 0.23 4.60 5.50 
  Middle 5.16 0.24 4.80 5.90 
  Older 5.14 0.23 4.50 5.60 
Younger 81.92 7.80 67.80 112.40 Waist girth 
(cm) Middle 92.09 17.23 65.25 138.75 
  Older 94.32 13.11 67.58 112.00 
 90
Table 6: Descriptive statistics separated into 3 age categories. Younger = 18-24 
years old, Middle = 25 – 44, Older = 45 – 65, m = meters, kg = kilograms, % = 
percent, BP = blood pressure, mmHg = pressure in millimeters of mercury, LDL = 
low density lipoprotein, mg = milligrams, dL = deciliter, HDL = high density 
lipoprotein, HbA1c = glycosylated hemoglobin, cm = centimeter. 
 
 
 
      
Table 7      
Percent Time in Each Activity Intensity By Day of Week 
Activity Level Vigorous Moderate Light  Sedentary 
Time 
(min) 8.6 76.7 290.2 1064.3 
std dev 9.9 38.1 74.0 93.9 
% of day 1% 5% 20% 74% 
All days 
std dev 
% 1% 3% 5% 7% 
Time 
(min) 9.7 80.5 286.3 1063.3 
std dev 11.9 42.4 82.4 106.2 
% of day 1% 6% 20% 74% 
Weekdays 
std dev 
% 1% 3% 6% 7% 
Time 
(min) 7.9 69.9 299.0 1063.0 
std dev 13.2 42.5 96.7 114.9 
% of day 1% 5% 21% 74% 
Weekend 
days 
std dev 
% 1% 3% 7% 8% 
 
Table 7: Comparison weekday versus weekend of time and percentage of day 
spent in each level of activity intensity. min = minutes, std dev = standard 
deviation, % = percentage. 
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increasing age. Sedentary and light activities were lowest in the youngest age 
group and increased with increasing age (table 8). 
Absolute risk A had the highest correlations with total activity counts (TAC) 
(r =-0.40), time in 5 minute bouts of moderate activity (Tmod) (r = -0.34) and time 
in 5 minute bouts of vigorous activity (Tvig) (r = -0.35). When observing intensity 
of PA in individual minutes accumulated for totals of 5 minutes up to 90 minutes 
(hct5 to hct 90), the highest correlations were found with Absolute risk A at r 
values ranging from r = -0.40 to r = -0.41 (table 9). Once it was established that 
absolute risk A had the highest correlations with activity counts, a stepwise 
regression revealed that hct30 provided the best fit regression line with r =  -0.41 
and the standard error of the estimate (SEE) at 0.55.   
When multiple regression analysis of CV risk was performed with both 
duration component and an intensity component, hct30 and Tmod provided the 
best fit line with r = - 0.422 and SEE = 0.55. The regression of hct5 and Tmod 
with CV risk resulted in r = 0.404 and SEE = 0.55. The multiple regression 
equation that provides a best fit line for CV risk for all subjects is CV risk = 4.298 
+ 0.006 (age) - 0.00009 (hct30), r = -0.434. 
When each gender was analyzed separately, the best fit regression line of 
absolute risk A for men was with total daily activity and age (r = - 0.53, SEE 
=0.58), [CV risk = 4.84 + 0.0026 (age) – 0.000002 (TDC)]. For women, hct30 and  
age had the best fit (r = -0.44, SEE = 0.50), [CV risk = 4.115 + 0.0079 (age) - 
0.000068 (hct30)]. When analyzed by age group, the best fit line for group 1 
(ages 18-24) was with hct5, r = -0.45, SEE = 0.40 and the best fit line for group 2 
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Table 8      
Percent Time in Each Activity Intensity By Age and Gender 
  
Vigorous Moderate Light  Sedentary  Sedentary and Light 
All 0.6% 5.3% 20.2% 73.9% 94.1% 
Younger 0.9% 6.1% 19.3% 73.7% 93.0% 
Middle 0.5% 4.7% 20.3% 74.6% 94.9% 
Older 0.3% 5.0% 21.3% 73.5% 94.7% 
Males 0.5% 6.0% 19.8% 73.7% 93.5% 
Females 0.6% 4.9% 20.4% 74.0% 94.5% 
 
Table 8: Comparison by age category and gender of percentage of day spent in 
each level of activity intensity. % = percentage. 
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Table 9             
                
Correlations of CV Risk Equations with Minutes of Activity Intensity  
CV risk 
equation 
average 
5 
minutes 
highest 
activity 
average 
10 
minutes 
highest 
activity 
average 
20 
minutes 
highest 
activity 
average 
30 
minutes 
highest 
activity 
average 
45 
minutes 
highest 
activity 
average 
60 
minutes 
highest 
activity 
average 
90 
minutes 
highest 
activity 
A -0.40 -0.41 -0.41 -0.41 -0.41 -0.41 -0.41 
B -0.33 -0.35 -0.35 -0.35 -0.35 -0.35 -0.35 
C -0.33 -0.35 -0.36 -0.36 -0.36 -0.35 -0.36 
 
Table 9: Correlations of each of the cardiovascular risk equations with multiple 
levels of physical activity intensity. CV = cardiovascular. All values listed in the 
table were significant at p < 0.05 level. 
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(ages 25-44) was with total counts, r = - 0.41 and the SEE = 0.71. A significant 
regression line was not found for Group 3 (ages 45-65) but total counts provided 
the best fit line at r = -0.33, SEE =0.53, p = 0.06. 
If the subjects were further divided into age categories by gender, the type 
of PA best correlated with CV risk in younger males was with the highest 
intensity 5 minutes (r = -0.49, SEE = 0.41) and in younger females was with the 
highest intensity 30 minutes (r = -0.50, SEE = 0.38). In both males and females 
aged 25 to 45 as well as males from 45 to 65, the best correlations were found 
with total counts per day (r = -0.63, r = -0.37 and r = -0.56 respectively). For 
females aged 45 to 65, there were no significant correlations found between any 
PA and CV risk. 
Discussion 
The results of this study affirm the relationship between PA and CV risk 
factors. Unique to this study is the characterization of the intensity and duration 
of PA in a way that was not previously possible. The introduction of 
accelerometers into PA measurement has enabled further exploration of activity 
intensity and duration specifics. It is now possible to examine and evaluate 
differences in activity patterns and assess the patterns of PA that best relate to 
the prevention of chronic diseases.  
Previous to the use of accelerometers, the standards for measurement of 
daily PA included self-report observations and cardiorespiratory fitness.256 The 
current recommendations are based primarily on research that used either 
fitness level or self-report to measure PA.2 It is well established that self-reported 
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Table 10       
     Correlations of CV risk A with PA by age & gender 
        
    Males     Females   
  18 to 25 25 to 45 45 to 65 18 to 25 25 to 45 45 to 65
Total counts 
per day 0.395 0.631* 0.560* 0.343 0.369* 0.183 
hct 5 0.488* 0.491 0.379 0.463 0.359 0.167 
hct 30 0.418 0.517 0.513 0.500* 0.343 0.189* 
 
Table 10: Highest correlations between cardiovascular risk A and accelerometer 
activity counts by gender and age category. CV = cardiovascular, PA = physical 
activity, hct 5 = highest intensity 5 minutes, hct 30 = highest intensity 30 minutes. 
* indicates highest r values for each group. 
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PA has an inverse relationship with CVD risk and that the relationship between 
fitness and CVD health is even stronger than that of self-reported PA.2, 256 
However, the measurement of fitness (VO2max) has a large genetic 
component 257, 258 and does not include the specifics of habitual activity such as 
total daily activity or time spent in moderate and vigorous activity. Because these 
measurement methods do not directly measure PA, doubt has remained as to 
the optimal parameters (frequency, intensity and duration) of exercise.256 Using 
accelerometers, it is possible to objectively assess the quality and quantity of PA 
as it is accumulated throughout the day. Previous findings have been confirmed 
and further information has been obtained regarding intensity and duration.  
A cross-section of an apparently healthy population (table 6) was 
sampled. Of the participants in our study, 67% met or exceeded 30 minutes of 
moderate (or higher) daily PA 5 of 7 days per week and 45% met these 
guidelines 6 of the 7 days per week. Depending on the definition of “most days of 
the week” these numbers are different than the survey data previously reported 
by the Centers for Disease Control (CDC) in which 60 % of the adult population 
was not regularly active 5 or more days per week.2  If regularly active is defined 
as 6 or more days a week, our numbers are closer to those reported by the CDC. 
Additionally, since subjects were recruited by students enrolled in a college upper 
division exercise physiology class, our sample may be more active than the 
general population. 
The PA patterns of our sample are comparable to that of other studies 
using accelerometers. In this investigation, 76.5 minutes per day were spent in 
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moderate activity while only 8.5 minutes per day were spent in vigorous activities. 
These results are similar to those observed by Buchowski et al. in a study of 
healthy adults’ in a southern US city. Approximately 1 hour per day was spent in 
moderate activities and less than 10 minutes was accumulated in vigorous 
activity.249 Non-sedentary minutes totaled 985 per day for men and 935 per day 
for women. Matthews et al. in a study of daily PA variance of healthy adults, 
observed time in non-sedentary activity was similar to the current study with 912 
minutes for men and 896 for women.140  
PA and CVD risk 
Correlational values for physical activity and CVD in the current study 
ranged from r = - 0.398 to -0.422 for all subjects. This is a clinically important 
finding. Previous researchers report correlations between physical activity and 
heart disease to be r = – 0.258239 and between physical activity and individual 
risk factors of blood pressure, BMI and HDL to range from r = 0.09 to 0.14.259 
Several quantification methods for PA intensity and duration were 
modeled. Total activity counts supplies information on the total amount of daily 
activity regardless of intensity. The time in moderate and vigorous categories 
allow assessment of duration at particular intensity levels. Evaluation of individual 
minutes of highest intensity, accumulated for periods of 5 to 90 minutes, allows 
assessment of short-term, high-intensity activity.  
Most previously reported data demonstrate that duration of moderate or 
above PA intensities is inversely related to CVD.56 Additionally, higher fitness 
levels (VO2max) are related to decreased CV risk.2, 124  In the current study, the 
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30 individual minutes of highest intensity accumulated (hct30) provided the best 
relationship with CVD risk (r = -0.41) for all subjects. Time spent in moderate and 
vigorous activity was significantly and inversely related to CV risk (Tmod: r = -
0.34, Tvig: r = -0.35) however, both total activity counts (TAC) and the 5 
individual minutes of highest intensity accumulated (hct5) were better associated 
with decreased CV risk (r = - 0.40). In addition, using both duration (Tmod) and 
intensity (hct 30) components in the prediction equations did not significantly 
improve the r values over using an intensity component alone.  
Intensity levels of activity were converted into MET levels using 
established prediction equations.255 The levels of intensity achieved in the hct5 
minutes ranged between 7 and 10 METs. This intensity corresponds to activities 
such as jogging, jumping rope, playing basketball, racquetball, soccer or singles 
tennis, backpacking or walking upstairs, walking 5 mph on a level surface, lap 
swimming, cross country skiing, and snowshoeing. The levels of intensity 
achieved in hct30 were between 5 and 9 METs. Activities in this range include 
cycling >10mph, low impact aerobics, dancing (such as square, line country, 
swing, polka), walking greater than 4.0 mph (15 min/mile), swimming, and 
walking upstairs. 
At higher intensities, duration may not be as important as originally 
thought. Instead, as Yu et al. suggest, attaining higher intensity levels for shorter 
time periods may be more beneficial for health benefits, particularly at younger 
ages.187  As noted in our study, reaching higher intensity levels for 1 minute 
periods accumulated for at least 5 minutes a day appears to be better related to 
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lower risk of CVD than longer durations of moderate or vigorous activity per day 
(table 10). This would be consistent with studies using fitness as a measure of 
PA124, 129 if VO2max is better related to the highest habitual intensity levels 
obtained than accumulated time in moderate activity. 
The results of the current study suggest that to reduce risk for CVD in 
apparently healthy individuals, longer durations of moderate or vigorous activity 
are important, but that 5 minutes of high intensity activity is better related to lower 
levels of CVD risk factors. This relationship is maintained up to the 90 individual 
minutes of highest intensity (table 8). The results of this study lend support to the 
need to incorporate PA throughout the day and the importance of including short 
periods of higher intensity activity. Furthermore, our data give further guidance 
about the required intensity and duration necessary to promote reduction of CV 
risk. As little as 5 individual minutes of higher intensity activity along with 
accumulation of moderate activity throughout the day may provide the best 
combination of PA related to inverse CV risk. 
Accelerometers have been proven valid and reliable instruments to 
determine habitual PA and to measure energy expenditure in ambulatory 
individuals. The accelerometer appears to overcome the subjective limitations of 
PA recall and additionally provides information on duration and intensity of PA 
that cannot be provided by other instruments such as pedometers or fitness 
testing. Using accelerometry to understand the relationship between both 
intensity and duration of PA with CV risk, it may become possible to improve both 
general and individual PA recommendations.  
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Limitations of the study 
Accelerometers are highly correlated to walking and jogging activities (r = 
0.89-0.99) 133, 138, 143 however there are limitations regarding type of activity being 
performed. Accelerometers placed at the hip are unable to detect increases in 
energy costs associated with upper body movement, changes in surface or 
terrain (walking, running or hiking uphill), or activities involving external work.260-
262 In these activities, activity would be underestimated. Also, an attempt was 
made to obtain a cross section of the local population however, because it was a 
sample of convenience, it may not be representative of the general population.  
Conclusions 
From these results, we conclude that the greater the volume of activity 
accumulated, the lower the CVD risk. However, the highest PA intensity levels 
achieved for durations as short as 1 minute, 5 times per day were more strongly 
associated with lower risk, particularly in younger individuals. These are clinically 
important findings because the correlational values obtained in this study are 
higher than those from previous studies and because additional information on 
the relationship between physical activity and CV risk has been uncovered. 
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CHAPTER 5 
EXAMINING HABITUAL PHYSICAL ACTIVITY AND CARDIOVASCULAR 
DISEASE RISK FACTORS IN STROKE SURVIVORS 
 
Abstract 
Purpose: The purposes of this study are to: 1. Compare the measurable 
risk factors for CVD and physical activity level between individuals after stroke 
and age-gender matched able-bodied controls. 2. Establish the relative intensity 
and duration of physical activity in a sample of stroke survivors. Managing 
cardiovascular disease (CVD) risk factors and increasing habitual physical 
activity (PA) have been shown to decrease risk of cardiovascular (CV) events in 
healthy individuals and those with coronary heart disease. Controlling CVD risk 
factors may also lower risk of CV events in stroke survivors. Because no studies 
have examined CVD risk factor levels in stroke survivors, it is uncertain how 
effectively CVD risk factors are managed in this population. Intensity and 
duration of PA are the basis of the current habitual PA recommendations from 
the American College of Sports Medicine. Neurological impairments from stroke 
decrease energy efficiency of movements thereby increasing energy costs of 
movement.  As a result, a higher intensity of PA is required for mobility and 
routine daily activities. If stroke survivors work harder than individuals without 
impairment to perform the same task, then fitness levels should be higher in 
stroke survivors unless other parameters of physical activity differ. Most of the 
data available on habitual PA in stroke survivors are collected through 
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cardiorespiratory fitness testing. Cardiorespiratory fitness is strongly associated 
with health benefits and directly related to habitual physical activity but does not 
provide the specifics of habitual PA such as intensity and duration. Observation 
of the intensity and duration of habitual activity would allow comparison of the 
relative intensities of physical activity in stroke survivors to the apparently healthy 
population. Methods: Complete data sets were collected on 16 subjects, 7 men 
and 1 woman each in the experimental and age-matched control groups. 
Experimental group participants had to be status post ischemic stroke for at least 
3 months, independent ambulators, with or without an assistive device and in 
good general health (medically stable). Resting blood pressure, height, weight 
and waist girth were measured. Fasting blood samples was analyzed for total 
cholesterol (TC), low density lipoprotein cholesterol (LDL), high density 
lipoprotein cholesterol (HDL), triglycerides, C-reactive protein and glycosylated 
hemoglobin (HbA1c). Habitual PA was assessed for 7 days with an 
accelerometer. Oxygen consumption and accelerometer data were recorded 
during a 6 minute walk test. From the 6 minute walk data, step counts were 
calculated for PA intensities of 3 and 6 METs. Means and standard deviations of 
descriptive variables and dependent variables were calculated within each group. 
T-tests analyses determined group differences comparing scores of stroke 
survivors to age matched controls. All significance levels were set at p < 0.05. 
Results: Elevated levels of systolic blood pressure (136.6 + 11.3 mmHg) and BMI 
(30.6 + 3.1 kg/m2) were observed in the stroke group. Significant differences 
between the stroke and control groups were found in body mass index (CI: 1.05 
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to 7.82 kg/m2) and systolic blood pressure (CI: 0.76 to 26.79 mmHg). No 
significant differences were found in diastolic blood pressure, waist girth, HDL, 
total cholesterol and HbA1c. During the 6 min walk, PA intensity was significantly 
lower in the stroke group (4.48 + 1.08 METs) than the control group (7.00 + 2.23 
METs, CI: -4.28 to -0.77 ml/kg/min). Total activity of the stroke group was 34% 
lower than the control group (CI: -222,283 to -25,198 counts). Daily time in 
moderate activity and above was 15.26 minutes for the stroke group and 32.36 
minutes for the control group. Physical activity of the stroke group was only 51% 
of the current national physical activity recommendations of 30 minutes of 
moderate activity most days of the week.  Conclusions: Risk of CV events was 
elevated in this sample of stroke survivors. Three out of 6 of the modifiable risk 
factors for CVD were present, blood pressure, obesity and sedentary lifestyle. 
Physical activity in this group of stroke survivors was well below the 
recommended intensity and duration for risk reduction of chronic disease, 
premature mortality and CV events. Neurological limitations of stroke promote a 
sedentary lifestyle. Cardiorespiratory fitness may need to be addressed 
separately from functional assessments of activities of daily living in the 
rehabilitation of stroke survivors.  Physical limitations must be overcome to 
provide the best outcome for these individuals and improve quality of life. 
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Introduction 
Cardiovascular (CV) events such as recurrent stroke and myocardial 
infarction are the leading causes of death in stroke survivors.263, 264 Up to 75% of 
stroke survivors have cardiovascular disease (CVD).263, 265, 266 Managing CVD 
risk factors such as hypertension, dyslipidemia, diabetes mellitus, and obesity 
along with increasing habitual physical activity have been shown to decrease risk 
of CV events in healthy individuals and those with coronary heart disease CAD.5-
9 Controlling CVD risk factors may also lower risk of CV events in stroke 
survivors. Yet CVD and its risk factors remain understudied in this population.267 
Although data exist on levels of individual CVD risk factors in stroke survivors, no 
studies are known to this author that compare CVD risk factor levels in stroke 
survivors to healthy age-matched individuals. Therefore, it is uncertain how 
effectively CVD risk factors are managed in stroke survivors.  
In the able-bodied, physical activity has been shown to be effective in 
controlling many individual CVD risk factors such as blood pressure, cholesterol, 
body mass index (BMI), and blood sugar.5, 9, 52, 164 It is likely that the health 
benefits of habitual physical activity in stroke survivors are similar to that of 
apparently healthy individuals.4 Until recently, little attention has been paid to 
habitual activity in stroke rehabilitation. Information provided by self-report 
questionnaires indicate that stroke survivors spend the majority of their day in 
sedentary activities.268  Other available information on physical activity in stroke 
survivors has been obtained through peak fitness testing (VO2max or VO2peak). 
Two separate studies published in 2005 reported peak fitness to be significantly 
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lower in a sample of subjects one year after a stroke event than in age matched 
controls.269, 270  
Although peak fitness testing provides information on habitual daily 
activity, it is generally not recommended in this population due to the increased 
risk of CV events when exercising at near maximal levels.223 Submaximal fitness 
testing is often used as an alternative to provide estimates of VO2max using 
prediction equations. An example of a submaximal test commonly used in stroke 
survivors is the 6 minute walk.223  
Most individuals regain independence in household ambulation after 
experiencing a stroke, however the majority do not regain sufficient aerobic 
capacity to function in the community and work outside the home.263, 271 Residual 
neurological impairments often affect mobility and the ability to perform routine 
daily activities. These neurological impairments can decrease energy efficiency 
of movements thereby increasing energy costs of movement.  As a result, a 
higher relative intensity is generally required for mobility and routine daily 
activities. If stroke survivors work harder than individuals without impairment to 
perform the same task then fitness levels should be higher in stroke survivors 
unless other parameters of physical activity differ.  
Whether submaximal or maximal, fitness testing represents the potential 
for physical activity and does not provide specifics of daily physical activity such 
as intensity and duration. Using a device like an accelerometer to monitor 
physical activity can provide objective information on intensity and duration of 
habitual physical activity with minimal lifestyle intrusion. Observation of the 
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intensity and duration of habitual activity would allow comparison of the relative 
intensities of physical activity in stroke survivors to the apparently healthy 
population. Using the information on habitual activity provided by accelerometers 
will also allow closer examination of the relationship between habitual physical 
activity and other CVD risk factors in this population. If the energy cost of 
physical activity is higher, does the relationship between physical activity and 
CVD risk factors also change?  
The purposes of this study are to: 1. Establish the relative intensity and 
duration of physical activity in a sample of stroke survivors. 2. Compare the 
measurable risk factors for CVD and physical activity level between individuals 
after stroke and age-gender matched able-bodied controls.  
Methods 
Informed written consent was obtained from all subjects and all 
procedures were approved by The University of Montana Institutional Review 
Board for Use of Human Subjects and conformed to the Declaration of Helsinki. 
Participants were recruited by convenience sampling through word of mouth and 
informational flyers. To be eligible for this study, experimental group participants 
had to be independent ambulators, with or without an assistive device, in good 
general health (medically stable) and status post ischemic stroke for at least 3 
months. Members of the control group were recruited to match age and gender 
of those in experimental group. Exclusion criteria for both groups included: recent 
infection or surgery within the past 3 months, uncontrolled or poorly controlled 
hypertension, and previous myocardial infarction, hemorrhagic stroke or 
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diagnosed cardiomyopathy. Complete data sets were collected on 16 subjects, 
with 7 men and 1 woman each in the control and experimental groups. 
Once recruited, the participants were asked to read and sign the consent 
form. Participants then completed the physical activity readiness questionnaire 
(PAR-Q) form272 and a medical history form to determine if they met the criteria 
of the study and to provide a list of medications. Once these forms were 
completed, a heart rate monitor was placed around the torso and participants 
completed the Physical Activity Scale for Individuals with Disabilities 
(PASIPD).273 Resting blood pressure was taken by a trained technician using a 
sphygnomometer and standard protocol.222 Pulse was monitored throughout the 
remainder of the seated period and the lowest observed number recorded. Then 
height, weight and waist girth were measured and recorded per protocol.223 
Activity Monitors  
Habitual PA was assessed with the Actical accelerometer (Mini Mitter, 
Bend, Oregon). After obtaining height and weight measurements, participants 
were fitted with accelerometers on the non-paretic (or dominant) hip and worn for 
a total of 7 days including a weekend period. Placing a single device on the hip 
or lower back is recommended.142 The monitors were secured at the hip with 
TegadermTM (3MTM, St. Paul, Minnesota) to ensure proper placement of the 
monitors. The participants wore the devices for 7 days and were able to shower 
and swim without restriction. Previous research has shown that in adults, a 
minimum of 3 to 5 days of monitoring is optimal to determine activity patterns.140, 
142  The period of 7 days was chosen to ensure inclusion of both weekend days 
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and weekdays. Log sheets were provided to record any activities such as riding 
or driving on a bumpy road that might overestimate activity and any times where 
they neglected to wear the device. 
The Actical activity monitors are small (2.8 x 2.7x1.0 cm3), lightweight 
(17g) units that have a primary plane of detection but are sensitive to all three 
planes of motion.248 The Actical is a piezo-electric accelerometer with a range of 
0.5 to 2G and frequency of 0.35 to 3.5 Hz. The Actical samples acceleration at a 
rate of 32 Hz and integrates this over the user-defined epoch.248 In this study, the 
epoch was set at 15 seconds, comprising an integral of 5760 measurements for 
each day.  
The 6-minute walk  
The 6-minute walk took place using an accelerometer and the portable 
metabolic system on a 200 ft rectangular loop. The participants were familiarized 
with the Borg 6-20 Rate of Perceived Exertion (RPE) scale, portable metabolic 
cart (VO 2000, Medgraphics, Minneapolis, Minnesota) and the Actical™ 
accelerometer. Heart rate was monitored via a polar heart rate monitor and 
activity was monitored by accelerometers on the non-paretic (or dominant) hip. 
Energy expenditure was assessed using the VO2000 portable metabolic system, 
a 1.5 lb device worn in a small back pack. The VO 2000 was calibrated before 
each test. The participant was asked to walk for 6 minutes around the designated 
loop and to cover as much distance as they comfortably could in that time period. 
During the testing, the participant used any assistive device normally used for 
walking and continuous monitoring of oxygen consumption and CO2 production 
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was performed. Heart rate was recorded every lap. Distance was measured to 
the nearest meter at the completion of the test. 
Timed up and go testing 
Participants were asked to stand up from a chair, walk 3 meters, turn 
around, return to the chair, and sit down. Time taken to complete this task was 
measured by a stopwatch and this task was repeated 3 times with the shortest 
recorded time used for data analysis. During the test, accelerometers on the non-
paretic (or dominant) hip monitored movement and participants were permitted to 
use any assistive device normally used for walking. 
A blood sample was collected from the participants within 2 weeks of the 
testing session detailed above. Participants were asked to fast for 12 hours prior 
to blood sample collection. Two 12ml vials of venous blood were drawn and 
analyzed at a hospital laboratory for lipids [total cholesterol (TC), low density 
lipoprotein cholesterol (LDL), high density lipoprotein (HDL), triglycerides], high 
sensitivity C-reactive protein (CRP) and glycosylated hemoglobin (HbA1c) to 
measure average blood glucose. Samples were analyzed for CRP, HbA1c and 
lipids enzymatically using an automated clinical chemistry analyzer (Roche-
Hitachi P-module, Indianapolis, IN) with estimation calculation of LDL cholesterol 
using the Friedewald equation.79  
Data analysis 
As the activity monitors were collected, the data was downloaded into a 
computer file using the Minimiter software. Using the activity log sheets 
completed by the participant, data for time periods that might overestimate 
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activity such as riding or driving on a bumpy road were eliminated. Also, all 
Actical files were screened for periods of zero activity. If the Actical was not worn, 
per report on the activity log sheet, this data was removed from the analysis. 
Because there are no published data available that relate oxygen 
consumption with activity counts in stroke survivors, analysis of this relationship 
was individualized for each subject. Ventilation and activity counts were 
concurrently recorded during the 6 minute walk. Using data from the last 3 to 4 
minutes of the 6 minute walk when oxygen consumption was steady, the counts 
per minute were averaged. Average metabolic equivalent (MET) level during this 
time period was also calculated. From this information, the numbers of counts 
per minute corresponding to 3 and 6 METs were calculated for each individual 
assuming a linear relationship between oxygen consumption and step count. 
These MET levels were selected because they are the established cutoffs 
between light, moderate and vigorous activity.252 From these data, time in 3 
activity intensity levels (< moderate, moderate, and vigorous) was determined for 
each individual during the 7 days of activity monitoring. Because only moderate 
intensity and above activity is considered cardioprotective, no attempt was made 
to differentiate between sedentary and light activity in this study. Average counts 
per day, average counts per minute, time in sedentary and light activity and time 
in moderate and above activity were used for statistical analysis. Using average 
counts per day quantifies total daily activity while utilizing average counts per 
minute allows for determination of activity intensity. 
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Statistics 
Means and standard deviations of descriptive variables and dependent 
variables were calculated within each group. Data analysis was performed both 
with all subjects and then with males only. T-tests analyses were used to 
determine group differences comparing scores of stroke survivors to age 
matched controls. When equal variances could not be assumed (Levine’s test for 
equality of variances) the more stringent values were reported. A p value of less 
than 0.05 was considered to be statistically significant. SPSS 12.0 (SPSS, Inc., 
Chicago, Illinois) was used for all data analysis. 
Results 
Complete data sets were obtained for eight subjects, 7 men and 1 woman 
in each group, stroke survivors and the control group. Means and standard 
deviations of descriptive variables appear in tables 11 through 14. Dependent 
variables included body mass index (BMI), waist girth, systolic and diastolic blood 
pressure (table 11), total cholesterol, LDL cholesterol, HDL cholesterol, CRP, 
blood glucose (HbA1c) (table 12), timed up and go (TUG), the 6 minute walk test 
(table 13) and accelerometer data (table 14). Analyzed accelerometer data 
included total activity, average intensity, and time in 3 intensities of activity 
(sedentary & light, moderate and vigorous). 
All subjects 
T-test results indicated significant differences between groups in BMI (CI: 
1.05 to 7.82 kg/m2), systolic blood pressure (CI: 0.76 to 26.79 mmHg), LDL 
cholesterol (CI: -73.68 to -16.46 mg/dl), TUG (CI: 1.06 to 23.07 seconds), 6 
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Table 11 
Descriptive Statistics and T-test Results 
Stroke Group Control Group 95% Confidence 
Interval   
Mean SD Mean SD Lower Upper 
Age (yrs) 63.67 9.03 61.33 8.00 -6.19 10.86 
Height (cm) 176.25 9.37 175.97 9.69 -9.24 9.81 
Weight (kg) 94.66* 11.24 80.46* 10.93 3.12 25.28 
Waist (cm) 105.80 11.61 96.67 9.97 -1.68 19.95 
SBP 
(mmHg) 138.56* 11.26 124.78* 14.58 0.76 26.79 
DBP 
(mmHg) 74.00 8.26 81.33 7.55 -15.24 0.57 
BMI (kg/m2) 30.50* 3.08 26.07* 3.66 1.05 7.82 
 
Table 11: T-test results for descriptive variables between experimental (stroke) 
group and control group displaying means, standard deviations and confidence 
intervals. SD = standard deviation, yrs = years, cm = centimeters, kg = kilograms, 
SBP = systolic blood pressure, mmHg = pressure in millimeters of mercury, DBP 
= diastolic blood pressure, BMI = body mass index, m = meters, * indicates 
statistical significance at p < 0.05. 
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Table 12   
T-test Results for Blood Sample Variables 
Stroke Group Control Group 95% Confidence 
Interval   
Mean SD Mean SD Lower Upper 
TG (mg/dL) 208.25 137.10 112.11 69.17 -23.34 215.62 
TC (mg/dL) 175.38 20.36 205.11 46.55 -67.29 7.82 
HDL 
(mg/dL) 55.13 11.12 54.22 14.51 -12.60 14.40 
LDL (mg/dL) 83.38* 16.86 128.44* 34.38 -73.68 -16.46 
HbA1c (%) 5.64 0.44 5.42 0.20 -0.13 0.56 
CRP 
(mg/dL) 0.33 0.36 0.09 0.07 -0.02 0.50 
 
Table 12: T-test results for blood sample variables between experimental (stroke) 
group and control group displaying means, standard deviations and confidence 
intervals. SD = standard deviation, TG = triglyceride, mg = milligrams, dL= 
deciliter, TC = total cholesterol, HDL = high density lipoprotein, LDL = low density 
lipoprotein, HbA1c = glycosylated hemoglobin, % = percentage, CRP = C-
reactive protein, * indicates statistical significance at p < 0.05. 
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minute walk distance (CI: -1,552 to -597.12 feet) and MET level during 6 min 
walk (CI: -4.28 to -0.77 ml/kg/min). With the accelerometer data, significant 
differences were found in average counts per day (CI: -222,283 to -25,198 
counts), average counts per minute (CI: -156.77 to -18.11 counts) and minutes  
per day spent in sedentary and light activity (CI: 11.65 to 77.25 minutes). Of note, 
differences in the time spent in moderate and above activity approached 
significance at p = 0.06. No significant differences were found in diastolic blood 
pressure, waist girth, HDL, total cholesterol and HbA1c. 
Males only 
Significant differences between the group with stroke and control group 
were found in BMI (CI: 0.20 to 7.50 kg/m2), systolic blood pressure (CI: 0.05 to 
27.95 mmHg), LDL cholesterol (CI: -64.47 to -19.70 mg/dl), TUG (CI: 0.03 to 
25.39 seconds), 6 minute walk distance (CI: -1601.34 to -500.54 feet) and MET 
level (CI: -4.11 to -0.28 ml/kg/min). Additional significant differences were found 
in C-reactive protein levels (CI: 0.01 to 0.27 mg/dl) and time in moderate and 
above activity (CI: -47.46 to -1.68). With the accelerometer data, significant 
differences were found in average counts per day (CI: -224,388 to -23,093 
counts), average counts per minute (CI: -158.17 to -16.71 counts) and minutes 
per day spent in sedentary and light activity (CI: 11.65 to 77.25 minutes). Also of 
note, differences in waist circumference approached significance at p = 0.06 and, 
because equal variance could not be assumed, triglycerides levels were not 
significantly different between groups (p = 0.051). No significant differences were 
found in diastolic blood pressure, waist girth, HDL, total cholesterol and HbA1c.
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Table 13   
T-test Results for Functional Tests 
Stroke Group Control Group 95% Confidence Interval   
Mean SD Mean SD Lower Upper 
Best TUG 
(seconds) 17.47* 14.32 5.41* 0.46 1.06 23.07 
6 min 
distance 1091.28* 606.64 2165.67* 208.07 -1,552 -597.12 
6 min METs 4.47* 1.08 7.00* 2.23 -4.28 -0.77 
 
Table 13: T-test results for functional tests between experimental (stroke) group 
and control group displaying means, standard deviations and confidence 
intervals. SD = standard deviation, TUG = timed up and go, 6 min distance = 
distance achieved in 6 minute walk test, 6 min METs = average energy 
expenditure during last half of 6 minute walk test, * indicates statistical 
significance at p < 0.05. 
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Table 14   
T-test Results for Accelerometer Data 
Stroke Group Control Group 95% Confidence Interval   
Mean SD Mean SD Lower Upper 
Total 
Activity 
(cts/day) 
65,057* 69,191 188,798* 121,077 -222,283 -25,198 
Average 
Intensity    
(cts per 
min)  
46.16* 49.34 133.59* 84.80 -156.77 -18.11 
Min/day     
Sed & Light 1,429* 14.58 1,385* 41.64 11.65 77.25 
Min/day 
Moderate 14.27 13.08 30.35 28.47 -38.21 6.07 
Min/day   
Vigorous 0.99 1.57 2.02 2.31 -3.00 0.95 
Min/day in 
Moderate & 
above 
15.27 13.45 36.43 28.31 -43.62 1.3 
 
Table 14: T-test results for accelerometer data between experimental (stroke) 
group and control group displaying means, standard deviations and confidence 
intervals. SD = standard deviation, Total activity = average number of counts per 
day for the 7 days, Average intensity = average daily counts per minute, cts = 
counts, min = minute, Min/day Sed & Light = total minutes per day spent in 
sedentary and light intensity activities, Min/day Moderate = total minutes per day 
spent in moderate intensity activities, Min/day Vigorous = total minutes per day 
spent in vigorous intensity activities. Min/day in moderate and above = total 
minutes per day spent in both moderate and vigorous intensity activities,   
* indicates statistical significance at p < 0.05. 
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Discussion 
Cardiovascular Disease Risk Factors: Although the risk of CV events such 
as myocardial infarction (MI) or recurrent stroke is elevated in stroke survivors, 
there are few data on CVD risk factors levels in this population. It is important to 
determine baseline levels of CVD risk factors in stroke survivors in order to effect 
changes in risk of CV events. Systolic blood pressure was significantly higher in 
the stroke group than in the control group. The mean systolic blood pressure for 
the stroke group was 136.6 mmHg which is classified as pre-hypertension. By 
comparison, those in the control group had a mean systolic pressure of 124.8 
mmHg, in the high normal range. Seventy five percent of the stroke group and 
50% of the control group were taking anti-hypertensive medication.  
Researchers have observed blood pressure control to be worse in stroke 
survivors than those suffering a myocardial infarction274 even though blood 
pressure control is essential for prevention of CV events.275 It is essential to 
maintain stringent control of blood pressure, particularly systolic. The risk of 
stroke and CVD associated with increasing systolic blood pressure is evident 
across the entire range of systolic blood pressure, independent of the level of 
diastolic blood pressure.276-279 Even small reductions in blood pressure decrease 
risk of stroke. Differences in blood pressure of 5, 7.5, and 10 mm Hg were 
associated with reductions in stroke incidence of 34%, 46%, and 56% 
respectively.17 The 11.8 mmHg difference in systolic blood pressure between the 
stroke and control groups in the current study is clinically important and indicates 
that these individuals continue to be at greater CVD risk.   
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Body mass index was also significantly higher in the stroke group than in 
the control group. The mean BMI was 30.6 kg/m2 in the stroke group with all 
subjects in either the overweight or obese range. Mean BMI in the control group 
was 26.07 kg/m2. Long term risk of CVD increases significantly with increasing 
levels of overweight and obesity.280 The higher the BMI, the greater the 
prevalence of myocardial infarction and stroke.281-283  Excess weight is 
associated with an increased risk of ischemic stroke independent of diabetes and 
other metabolic syndrome components.284 Each 2 kg/m2 increase in baseline 
BMI is associated with a 15.4% increase in relative risk of CHD and an 18.8% 
increase in relative risk of ischemic stroke. Conversely, reduction of BMI to under 
24 might prevent the incidence of CHD by 11% and that of stroke by 15% for 
men, and 22% of both diseases for women.282 In the current study, the higher 
BMI values found in the stroke group indicate increased CVD risk.  
In males, CRP values were higher in the stroke group than the control 
group (0.21 mg/dL versus 0.07 mg/dL). Normal concentration levels in the 
plasma are less than 0.5 mg/L or 0.05 mg/dL.79 Cardiovascular risk levels are 
stratified into low, moderate, and high corresponding to CRP levels of <0.1, 0.1 to 
0.3, and > 0.3 mg/dL.102   Levels of CRP can assist with risk prediction of cardiac 
events in healthy individuals77, 89, 90, 93 and after an ischemic event.285  In previous 
studies, CRP was the single strongest predictor of CV event risk80 even after 
controlling for other Framingham risk scores.73 C-reactive protein level is also a 
risk predictor for stroke73, 286-288 and recurrent ischemic stroke.289-291 By 
controlling CVD risk factors, CRP levels may also be lowered. Obesity, blood 
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pressure, diabetes and smoking were all positively associated with levels of 
inflammation as measured by CRP.57 Increases in physical activity and 
decreases in blood pressure have been inversely related to CRP levels.292 
Values below 0.3 mg/dL are considered to be useful in prediction of CV risk. The 
findings of the current study are clinically important and consistent with the 
literature on CRP indicating the individuals in the stroke group may be at higher 
risk for CV events. 
Differences in LDL cholesterol levels were also observed. Although LDL 
cholesterol levels were significantly higher in the control subjects, the levels were 
less than what is considered elevated (> 130 mg/dl).293 Seventy five percent of 
the participants in the stroke group (6 of 8) were on medications for lipid 
lowering. This may indicate that cholesterol is being managed effectively in the 
stroke survivors. Only 1 of 8 participants in the control group was being managed 
with medications for dyslipidemia. Medical management of cholesterol levels less 
than 130 mg/dL is not recommended for those not at high CVD risk. 223, 293  
Blood sugar, diastolic blood pressure and lipid levels were within normal 
limits for the stroke group however, elevated levels of systolic blood pressure and 
BMI were observed in all subjects and CRP levels were significantly higher than 
the control group in males. Hypertension, obesity and low grade inflammation 
have been related to increased risk for CV events. From these observations, this 
sample of stroke survivors presents with a higher CVD risk than the control group 
even without considering the additional risk from having a history of a CV event. 
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Daily Physical Activity 
The American College of Sports Medicine and Center for Disease Control 
recommend at least 30 minutes of accumulated moderate activity most days of 
the week for reducing CVD risk.56 Habitual physical activity is important in 
moderating CVD risk factors. In apparently healthy individuals, routine physical 
activity decreases cardiovascular disease (CVD),4, 45 lowers blood pressure5-9 
lowers body fat,5, 9 and decreases systemic inflammation.47-49 Although physical 
activity assessments have previously been made in stroke survivors, until 
recently it was difficult to objectively measure intensity and duration of physical 
activity. 
Habitual activity levels were significantly less in the stroke group than in 
the age matched control group. Total activity of the stroke group was 34% lower 
than the control group as measured by counts per day of 65,057 versus 188,798 
respectively. Intensity of physical activity was also lower in the stroke group. 
Average counts per minute differed by 87 counts/min with the stroke group 
averaging 46.16 counts per minute and the control group averaging 133.59 
counts per minute. Time in moderate activity and above was 15.26 minutes for 
the stroke group versus 32.36 minutes for the control group. The time stroke 
survivors spent in moderate and above activity was only 42% of the control 
group. Michael and Macko recently observed steps per day in stroke survivors to 
be approximately 35% of sedentary adults.294 The PA in the stroke group was 
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only 51% of the current national physical activity recommendations of 30 minutes 
moderate activity most days of the week.56 
Following completion of rehabilitation, stroke survivors often adopt a 
sedentary lifestyle.295, 296 Average time in sedentary activities or sleeping was 17 
hours per day with 1 of every 6 individuals sedentary or sleeping for all 24 
hours.268 From these data, it is clear that stroke survivors are habitually less 
active than their age-matched counterparts. By remaining sedentary, 
cardiovascular fitness declines, eventually causing further loss of functional 
abilities. Without ample daily activity, risk of CVD is increased. Emphasis on the 
importance of increasing physical activity is vital to assist in controlling future risk 
of CV events. The sample of stroke survivors in the current study exhibited 
habitual activity consistent with findings of previous studies and well below the 
amount considered to be cardioprotective in healthy adults.  Both duration and 
intensity of physical activity was far less in the stroke group than that of the 
control group and well below the physical activity recommended by the ACSM for 
reduction of health risks.223, 297, 298 
Functional Assessments 
The results of both the TUG and 6 minute walk are consistent with other 
studies of stroke survivors. Mean TUG times were 17.5 + 14.3 seconds for the 
stroke survivors. This is 3.2 times slower than the age matched group. Other 
researchers have reported average TUG times of 13.7 to 25.2 seconds for those 
with stroke.299-304 Mean 6 minute walk distance was 332 meters for stroke 
survivors, 50% lower than the control group. Six minute walk distances observed 
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in previous studies of stroke survivors ranged from 202 to 491 meters.299, 305-311 
In 2 separate studies, distances achieved in the 6 minute walk were 40 to 50% 
less than expected.308, 312 In the current study, this sample of stroke survivors 
appears to be representative of the population because values observed for the 
TUG and 6 minute walk are within the observed ranges of previous studies. 
Stroke survivors exhibited significantly lower oxygen consumption (VO2) 
during the 6 minute walk test than age matched controls. The mean oxygen 
consumption observed in the current research was 15.67 ml/kg/min or 4.48 
METs, 58.6% of the age and gender matched controls.  Oxygen consumption of 
stroke survivors ranged from 8.3 to 16.1 ml/kg/min in previous research313-315 
with peak oxygen consumption observed to be significantly lower in participants 
who had a stroke than in age and gender matched controls.269, 270 Fitness in 
those with stroke has been observed to be 40 to 60% of healthy age-matched 
population.311, 315-317 Current ACSM recommendations for minimal physical 
activity call for 30 minutes of moderate activity most days per week with 
moderate activity defined as activity requiring 3 to 6 METs or 10.5 to 21ml/kg/min 
of oxygen consumption. The stroke survivors in this study were able to achieve 
moderate level activity averaging 4.48 METs in the 6 minute walk test. Therefore 
it is possible for stroke survivors to meet current guidelines for physical activity. 
At 60 years old, a peak VO2 above 25 ml/kg/min is considered normal for 
women and a peak VO2 above 32 ml/kg/min is considered normal for men.252 
Although normal peak VO2 values are different in men and women and decrease 
with age, the observed VO2 values of stroke survivors are well below the energy 
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cost for most ADLs.269 This is an important observation, that many stroke 
survivors do not have the fitness required for independent living, even if their 
functional ability is present. Furthermore, an exercise capacity of below 21 
ml/kg/min or 6 METs is associated with an increase in mortality.269  
Performance in the 6 min walk test can be more strongly influenced by 
limits to walking speed such as balance.305, 309, 318 Variances in long distance 
walking were largely explained by balance for those who walked more slowly and 
fitness for those who walk more quickly.319 The neurological impairments caused 
by stroke can limit walking speed or distance preventing the cardiovascular 
system stress that improves fitness.320 It is likely that in stroke survivors, the 
walking speed observed in the 6 minute walk is the maximum speed that the 
individual can achieve in that task. In the majority of stroke survivors, walking is 
probably the most demanding daily living activity they perform. As a result the 
aerobic capacity of stroke survivors is likely similar to the oxygen consumption at 
their highest walking speed. For this sample of stroke survivors, oxygen 
consumption averaged 15.67 ml/kg/min, well below the 21 ml/kg/min exercise 
capacity associated with increased mortality. 269  
If the walking speed is limited by balance, fitness may need to be 
separately addressed using activities other than independent walking to reach a 
sufficient intensity to challenge the cardiorespiratory system. It is possible to 
increase cardiovascular capacity of individuals after stroke. Treadmill walking 
with body weight support, stationary cycling and stepping exercises have been 
successfully utilized to increase endurance and walking efficiency.269, 270, 321  
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Conclusions 
It is important to uncover the particulars of physical activity to understand 
its relationship to CVD risk. Once the relationship is established, it may be 
possible to study the effects of increasing activity on CVD risk factors in this 
population. With the increased risk of CV events in survivors of stroke or heart 
attack, secondary prevention is essential. This is the first study relating multiple 
CVD risk factors to physical activity levels in stroke survivors. Three out of 6 of 
the modifiable risk factors for CVD were present in this sample of stroke 
survivors. Stroke survivors presented with elevated blood pressure, increased 
body mass, and a sedentary lifestyle and are already at increased risk due to 
history of CVD and age. That means that 5 of 8 risk factors of CVD are present in 
these individuals. Higher CRP levels may indicate risk of stroke or myocardial 
infarction is further amplified.  
It is imperative to control CVD risk factors in stroke survivors. Besides 
pharmacological management, increasing habitual activity should be encouraged 
whenever possible. The major challenge is that neurological limitations of stroke 
and extra effort required for even the most common activities such as walking, 
promotes a sedentary lifestyle. Cardiorespiratory fitness may need to be 
addressed separately from functional activities of daily living in the rehabilitation 
of stroke survivors. Physical limitations must be overcome to provide the best 
outcome for these individuals and improve quality of life.  
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CHAPTER 6 
CONCLUSIONS 
 
The purpose of this collection of studies was to explore the association of 
physical activity with CVD and attempt to identify some specifics of this complex 
relationship. Current physical activity recommendations call for 30 minutes of 
moderate activity most days of the week or 20 minutes of vigorous activity 3 days 
per week. From these recommendations it appears as intensity increases, 
duration decreases. The activity accumulation intervention provided in the first 
study fits within this continuum. Simply by increasing volume of physical activity 
through increases in step counts some of the modifiable CVD risk factors were 
improved. However, if the intensity or duration were further increased, additional 
improvements in CVD risk factors may occur.  The activity accumulation 
programs were successful in initiating increases in physical activity and positive 
changes in CVD risk factors. To successfully provide additional improvements in 
risk factors, adding an intensity component may be optimal.   
The optimal intensity and duration of physical activity may change as one 
ages. In younger adults, total activity amount was inversely related to CVD risk, 
however, higher intensity activities accumulated for periods as short as 5 minutes 
provided the best correlations with CVD risk scores. As age increases, this 
relationship may diminish and total volume of accumulated activity may be more 
important. The highest correlations were observed for total activity in adults ages 
25 to 45 and it appeared that with a larger sample size, the relationship may 
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continue in the 45 to 65 age range. Further investigation into this relationship in 
these age ranges may clarify these observations.  
In the study of apparently healthy individuals and stroke survivors, the 
inverse relationship between CVD risk factors and physical activity appears to be 
maintained. Physical activity in the control group was almost double that of the 
stroke survivors. Of the modifiable CVD risk factors measured, 3 were present in 
stroke survivors while none were observed in the control group. Although the 
relative intensity of daily activities in stroke survivors may be much higher than 
age matched controls for walking and other activities of daily living, it appears 
that this sample did not sustain these intensities for adequate durations to attain 
the cardioprotective effects of physical activity. A larger sample size would be 
recommended to make further conclusions about these groups. 
In this series of studies, the inverse relationship between CVD and 
physical activity has been confirmed. Through the use of activity monitors, 
additional insight into intensity and duration specifics has been accomplished. 
Much has been learned about the relationship between CVD risk and physical 
activity. In general, greater volumes of physical activity provide decreased risk 
however intensity and duration play important roles in this complex relationship. 
There is much more to be revealed about this association through further studies 
of specific age groups and of special populations as well as through various 
methods of increasing physical activity.  
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